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ABSTRACT 
 
Bone is a connective tissue with nanosized particles of carbonated apatitic 
calcium phosphate dispersed in a hydrated collagen matrix. With the ageing of the 
baby boomer population, an increasing number of people sustain bone fractures 
and defects. Hence, efforts are underway to develop materials to hasten the 
healing and repairing of such defects. These materials are termed as artificial bone 
substitutes.  
This study represents innovative techniques for development of bone 
implant materials and improving the existing substitute materials. Emphasis was 
on three different kinds of materials: Metals (titanium and alloys), Ceramics 
(calcium phosphates), and Polymers (collagen). The bioactivity of titanium and 
alloys, resorptivity of calcium phosphates and biocompatibility of collagen were 
the major issues with these materials. These issues are appropriately addressed in 
this dissertation. For titanium and alloys, biomimetic coating methodology was 
developed for uniformly and evenly coating 3-D titanium structures. Cracks were 
observed in these coatings and a protocol was developed to form crack-free 
biomimetic coatings. In calcium phosphates, increasing the resorption rate of HA 
(hydroxyapatite) and decreasing the resorption rate of β-TCP (β-tricalcium 
phosphate) were studied. HA-based ceramics were synthesized with Na+ and 
CO32- ions dopings, and development of biphasic mixtures of HA-β-TCP and HA-
Rhenanite was performed. Similarly, β-TCP ceramics were synthesized with Zn2+ 
ion doping and development of β-TCP-HA biphasic mixtures was performed. In 
case of collagen, a biomimetic coating process was developed that decreased the 
time to coat the collagen substrates and also increased biocompatibility, as 
determined by the response of mouse osteoblasts.  
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CHAPTER 1 
 
INTRODUCTION 
 
Bone graft or osteal implant surgery has been a topic of research for many 
years due to ever-increasing demand for bone substitutes. An estimated 2 million 
people sustain bone fractures each year in the United States as a result of activity 
or trauma.1 This procedure replaces missing bone with material from either the 
patient's own body (autograft), natural substitute (allograft) or a synthetic material 
(artificial graft). The most desirable implants are those which are autogenous and 
allogenic since no immune rejection occurs. However, sufficient material cannot 
always be derived from the patient or a suitable donor and current medical 
technologies are not yet able to synthesize these materials.  As a consequence, 
artificial materials are substituted. In contrast to the previous methods, abundant 
resources are available to produce artificial replacements. In this research, 
emphasis is laid on three kinds of artificial materials: Metal (Titanium and 
alloys), Ceramics (calcium phosphates) and Polymer-Ceramic Composite 
(collagen-calcium phosphates). 
 
1.1 Titanium and alloys 
Titanium and alloys are important materials for biomedical and dental 
implants due to their lower modulus, superior biocompatibility and better 
corrosion resistance when compared to more conventional stainless and cobalt-
based alloys. This is due to the factor that titanium (and alloys) readily forms a 
thin surface oxide layer upon contact with either air or fluids.  They are generally 
regarded to have good biocompatibility but are relatively bioinert, that is, they do 
not bond to bone. Upon implantation, titanium (and alloys) is thereby recognized 
as a foreign material and the body tries to isolate it by encasing in fibrous tissues.  
The process of fibrous encapsulation is described as follows.2,3,4 After 
implanted into body, neutrophils and macrophages are first noted on the implants,  
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followed by the formation of foreign body giant cells from activated 
macrophages. It is generally accepted that osteoprogenitor cells migrate to the 
implant site and differentiate into osteoblasts that make bone. After the materials 
have been implanted into the body, the first stage in the reaction (after interaction 
with water and ions) is non-specific protein adsorption. Afterwards, neutrophils 
and macrophages interrogate the implant. The macrophage interaction and 
cytokines released by the macrophages are believed to attract fibroblasts and drive 
the foreign body encapsulation process.2,3,4 
This leads to poor adhesion of titanium implant with the bone which is 
attributed only to the mechanical interlocking of titanium surface roughness and 
pores of bone. It was noted that the implant and bone is separated by a thin non-
mineral layer.5 The material surface plays an extremely important role in the 
response of the biological environment to the artificial implants. In order to make 
titanium biologically bond to bones, surface modification methods have been 
proposed to improve the bioactivity of titanium (and alloys).  
Surface modifications can be performed by either physical or chemical 
methods. The physical methods are used to deposit a layer of bioactive calcium 
phosphates on the titanium surface. The most preferred calcium phosphate coating 
that is performed is that of hydroxyapatite because of its similarity to the mineral 
phase of natural hard tissues. 6-9 Current hydroxyapatite physical coating methods 
can be broadly categorized as follows: (1) Plasma Spraying,10-12 (2) Dip 
Coating,13-17 (3) Sputtering,18-27 (4) Electrophoretic Deposition,28-35 and (5) Pulsed 
Laser Ablation36-38. Due to use of very high temperatures in most of these 
processes, a change in chemical composition and structure of the hydroxyapatite 
coating takes place, reducing its adhesion to the substrate, decreasing its 
bioactivity, and thereby limiting its use.2 This disadvantage is overcome by using 
chemical methods that are performed at relatively lower temperatures.  
Current chemical modification techniques involves treating the surface 
with either acid,39-42 hydrogen peroxide,43-47 or a strong base48-55 followed by a 
heat treatment step which converts the layer from amorphous to crystalline. The 
layer produced induces apatite forming ability on the metal surface and exhibits 
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bone-bonding ability. Other common ways of chemical treatments are sol-gel 
coatings,56-59 anodic oxidation,60-64 and SBF-based biomimetic coating65-69 
techniques. Of these processes, only SBF-based biomimetic coatings employ 
physiological conditions that is, in a solution at a pH 7.4 and 37°C, to coat. The 
most important advantage is that the formed coatings retain carbonates and are 
similar to the biological apatites. In a recent study it was shown that SBF-coated 
titanium substrates behaved better with the osteoblast cells than alkali-treated or 
pristine titanium substrates.69  
The biomimetic coatings are formed by soaking an alkali pre-treated 
titanium (or an alloy) substrate in a simulated body fluid (SBF) solution. The 
alkali pre-treatment is a crucial step, which forms a hydrous sodium or potassium 
titanate layer (depending upon the alkali used) on the substrate.68,70-72 The as-
formed sodium (or potassium) titanate on soaking in SBF exchanges Na+ (K+) 
ions with the H3O+ ions and forms Ti-OH groups on the surface that increases the 
ionic activity of apatite in SBF.73 During soaking, nanometer sized apatitic 
calcium phosphate globules rapidly nucleate on the sodium (or potassium) titanate 
layer and then grow to a few microns by consuming Ca and P ions from the SBF 
solution.71 
There are several different SBF solutions recipes available in the 
literature.74-78 It was found out that different SBFs lead to different amount and 
type of coating. Recently, the apatite inducing abilities of 3 different SBF 
solutions referred to as c-SBF, t-SBF and r-SBF on these alkali treated titanium 
substrates was investigated.69 c-74 and r-SBF75,76 are conventional and revised 
versions of SBF, as developed by Kokubo. t-SBF77,78 is the formulation developed 
by Tas.  The compositions of the three SBF solutions and the important 
differences between them are given in ref 69. It was noted that t-SBF solutions 
with an HCO3− concentration of 27mM are able to coat titanium strips more 
quickly than c-SBF solutions.69 Another important conclusion from this study was 
that the osteoblast response was better for coatings produced by t-SBF than r-SBF 
solutions.69 These initial results were taken into consideration and a biomimetic 
coating methodology was developed for uniformly and evenly coating 3-D  
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structures utilizing t-SBF (Chapter 2).  
In spite of all the advantages of biomimetic coatings, it was noted that 
cracks were persistently present on these apatitic calcium phosphate coatings 
irrespective of the composition of the coating solution. A major consequence of 
the presence of these cracks substantially increases the chances of delamination. 
Thereby, decreasing the coating’s bonding ability with the natural bone. Hence, 
reasons for the formation of such cracks was found and a protocol for producing 
crack-free homogeneous biomimetic coating on Ti6Al4V utilizing t-SBF was 
established (Chapter 3). 
 
1.2 Calcium Phosphates 
Apart from titanium and alloys, several other ceramic materials have been 
discovered that have good biocompatibility. These are known as Bioceramics. 
Materials that can be classified as bioceramics are: Alumina, Zirconia, Calcium 
phosphates, Silica based glasses or glass ceramics, and Pyrolytic carbons.79 This 
research work consists focusing on research and development of calcium 
phosphate materials for implants. There are several calcium phosphates that found 
use in the biomedical field and are as follows: tetra-calcium phosphate [TTCP, 
Ca4(PO4)2O], tri-calcium phosphate [α-TCP, α-Ca3(PO4)2  and β-TCP, β-
Ca3(PO4)2], di-calcium phosphate anhydrous [DCPA, monetite, CaHPO4] and di-
calcium phosphate dihydrate [DCPD, brushite, CaHPO4.2H2O]. However, most 
commonly used calcium phosphate as substitute material is sintered HA. This is 
because HA is closely similar in chemical composition, structure, and 
physicochemical properties to the mineral component of the osseous tissue.80,81 
Another calcium phosphate that has recently become a subject of increased 
interest is sintered TCP, due to its increased resorption rate.82,83 But both these 
materials experience some problems, which are highlightened in this section and 
appropriate solutions are suggested. 
Before proceeding further, it is important here to understand the bone 
material and its remodeling process. Bone is a connective tissue with extracellular 
substance consisting of a carbonated, apatitic calcium phosphate nanosize mineral 
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dispersed in what is essentially a hydrated collagen matrix.84-86 All bones consist 
of living cells embedded in the mineralized organic matrix, which are: the matrix-
forming osteoblasts, the tissue-resorbing osteoclasts, and the osteocytes.86,87 
Osteoblasts are the cells present in bones which actually build the extracellular 
matrix and regulate its mineralization. The lifespan of an osteoblast ranges up to 8 
weeks in humans, during which time it lays down 0.5 to 1.5 prm osteoid per 
day.86-88 Osteoclasts, on the other hand, are able to resorb fully mineralized bone 
as they are equipped with a variety of enzymes which lower the local pH to values 
between 3 and 4. Osteocytes are the principal (they account for about 90% of all 
cells in the adult skeleton) cells present in adult bones, and their special 
construction may actually orchestrate the spatial and temporal recruitment of the 
cells that form and resorb bone. Modeling is the processes whereby bone is laid 
down onto available surfaces, whereas in remodeling, osteoclastic resorption of 
bone leaves pockets that are then filled by osteoblast activity.87 When the bones 
no longer have any osteoblasts or osteoclasts, the modeling/remodeling processes 
would cease.  
Calcium phosphate-based bone substitute materials should ideally be 
implanted with the design consideration that the osteoclastic resorption will be 
able to slowly and gradually degrade the bone substitute material, and in the 
pockets created by the osteoclasts, new bone will be deposited by the 
osteoblasts.86,87 If a material is not resorbed by the osteoclasts, then it can not be 
used as a bone substitute bioceramic, which can take part in bone turnover. On the 
other hand, if an implant material is simply soluble in physiological fluids, then it 
can not help much in the bone remodeling processes. This is due to the lack of 
that precise interaction and crosstalk between the resorbing osteoclasts and 
depositing osteoblasts, which must occur.86 
 
Following observation of the behavior of bioceramics in vivo, it was determined 
that the essential requirement86 for bonding of the implant is that it should: 
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1. readily take part in bone remodeling ( i.e., osteoconduction the direct 
anchorage of an implant by bony tissue surrounding it, without the growth of 
fibrous tissue at the bone implant interface), 
2. itself cause the formation of bone tissues ( i.e., osteoinduction), even if it is 
not in interfacial contact with natural bones, 
3. maintain its mechanical strength during the intermediate stages of cellular 
(i.e., osteoclasts) active resorption, and 
4. be gradually but fully replaced, within 48 to 52 weeks, by new bone (i.e., 
osseointegration) at the implantation site. 
 
HA or β-TCP implants exhibit relatively good tissue compatibility, and new 
bone is formed directly on the implants with no fibrous encapsulation.89 However, 
sintered and well-crystallized HA ceramics usually demonstrated minimal in vivo 
resorption, with resorption times lagging the new bone formation rates.90-94 
Literature reports the lack of full participation of sintered HA implants in the bone 
remodeling processes even a year after their implantation.95  Kilian et al.96 showed 
that nonsintered HA could even be phagocytized and dissolved by macrophages 
and osteoclasts, while sintered ceramics did not degrade and remained at the site 
of implantation for years following the surgery. β-TCP, on the other hand, has a 
significantly high solubility97,98 and typically fades away from the defect site even 
before the completion of new bone formation. . It was shown that the dissolution 
rate of β-TCP (i.e., 1.26x10-4 mol/m-2 min-1) in an aqueous solution at a pH of 
about 6 was about 89 times greater than that of carbonated apatite (1.42x10-6 
mol/m-2 min-1).97 As an implant the higher dissolution rate of β-TCP may result in 
premature loss of mechanical strength. 
An ideal skeletal repair implant should readily take part in the bone 
remodeling processes, and also allow for the direct anchorage by the bony tissues 
surrounding it (osteoconduction).99 If the skeletal repair implant itself causes the 
in situ formation of the mineral part of the bone tissues (osteoinduction) rich in 
carbonated, apatitic calcium phosphates,100 while it is continuously resorbing (in 
vivo osseointegration), this could be its most effective repair method of the defect 
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site.86,101-103 This is similar to the mineral phase of human bones. Loty et al.104 
described the mechanism of the binding between bones and the bone-like apatite 
layer. The osteoblast cells proliferate on the bone-like apatite layers, and form a 
biological matrix containing apatite and collagen whilst consuming the apatite in 
the bone-like apatite layer and then remodeling the layer. This bonding process 
between artificial materials and natural bone is identical to that involved in the 
bonding between natural bones.104 Therefore, efforts in the direction of 
developing calcium phosphate-based bone substitutes of higher in vivo 
resorbability and osteoinductive/osteoconductive capabilities are still needed. 
Therefore, the main line of research for HA-containing biomaterials was to 
increase the resorption/solubility rate of the implant material. This can be 
achieved by: 
(1) Preparation of nonstoichiometric HA by modification of the HA structure with 
foreign ions (Na+ / K+ / Mg2+ / CO32-);  and 
(2) Design of poly-mineral composites incorporating HA and other calcium 
phosphates.  
 
In the first instance, resorption depends on the structural perfection of HA: 
nonstoichiometry, type of solid solutions, site occupancies, and distribution of the 
effective charge in the presence of foreign cations. The apatite structure is very 
hospitable and allows substitutions of Ca2+, PO42- or OH- sites with other ions.79-81 
There is evidence in literature that substitution results in changes in properties like 
lattice parameters, morphology, and most importantly solubility without 
significantly changing the hexagonal symmetry.79 Undoubtedly, HA doped with 
low concentrations of select elements may promote bonding of orthopedic/dental 
implants to juxtaposed bone due to its similarity with the biological apatite / bone 
mineral. Therefore, our aim was first, to synthesize HA ceramics with Na+ and 
CO32- ions dopings and then, to evaluate their bioactivity and biocompatibility 
(Chapter 4). 
As for the second line of research, a composite is formed of HA with other 
calcium phosphates. The log Ksp values for all calcium phosphates is shown in 
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Table 1.1. The table clearly shows that HA has the lowest dissolution rate 
whereas all other calcium phosphates dissolve much faster than HA. Therefore, 
making a composite of HA with other calcium phosphate will definitely improve 
the resorption rate of the material in vivo. However, β-TCP has been a choice of 
material since it fully resorbs in human tissue, whereas other phosphates 
experience weak resorption and belong to the class of resistive compounds. 
Jarcho105,106 points out that the resorption rate of implants is proportional to the 
TCP content: increasing the fraction of HA reduces the resorption rate.  
Other materials can also be used to make a composite. The criterion 
followed in selecting these materials is that they should (1) promote bioactivity, 
(2) enhance cellular proliferation, and (3) possess high solubility and increase the 
degradation rate of the composite. Thus, innovative techniques were employed to 
synthesize HA-TCP (Chapter 4) and HAP-Rhenanite composites (Chapter 5).   
 
For β-TCP-containing biomaterials, the line of research followed consists of: 
(1) Design of poly-mineral composites of β-TCP and HA; 
(2) Stabilizing the structure of β-TCP. 
 
 
 
 
Table 1.1 Solubility products of different calcium phosphates 
 
Chemical Formula Name Ca/P -log Ksp at 25ºC 
Ca(H2PO4)2 MCPA 0.5 highly soluble 
Ca(H2PO4)2.H2O MCPM 0.5 highly soluble 
CaHPO4 DCPA 1.0 6.90 
CaHPO4.2H2O DCPD 1.0 6.59 
Ca8H2(PO4)6.5H2O OCP 1.33 96.6 
α-Ca3(PO4)2 α-TCP 1.5 25.5  
β-Ca3(PO4)2 β-TCP 1.5 28.9 
Ca10(PO4)6(OH)2 HA,  1.67 58.4 
Ca4(PO4)2O TTCP 2.0 38.0 
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The first one is similar to that of HA, wherein composites of β-TCP and 
HA are formed which lead to an optimal resorption rate and enhanced cellular 
proliferation (Chapter 4). The second line of research depends on the stabilization 
of the β-TCP structure. It was shown that when the β-TCP structure was 
stabilized, the dissolution rate decreases, providing better mechanical properties. 
This stability in structure can be achieved by substituting the larger Ca2+ (0.099 
nm) ions with smaller divalent cations, such as Zn2+ (0.074 nm)107,108 or Mg2+ 
(0.072 nm)109 ions. Therefore, different range of Zn-doping from pure β-TCP to 
1.0 wt% Zn-doped β-TCP was synthesized and we examined the effect of Zn-
doping on dissolution and biocompatibility (Chapter 6). 
 
1.3 Collagen-Calcium Phosphates Composite 
A composite of collagen and apatite is of special interest because of their 
compositional similarity with bone.110-113 In recent years, there is an increased 
effort to produce apatite-collagen composite materials by innovative biomimetic 
processing.113-120 Biomimetic coating process is employed to coat collagen 
substrates to synthesize the apatite-collagen composites.121-129 This process is 
similar to that employed for titanium and alloys, which involves soaking the 
substrate in a SBF solution, wherein several-micron-thick bioactive layers of 
apatitic calcium phosphate nano-aggregates is deposited. It was noted that even 
after 4 weeks of soaking time, the collagen surface was not fully covered by 
apatitic calcium phosphates.122 Several modifications to the biomimetic coating 
process were employed by altering the normal soaking procedures, which led to 
increase in bioactivity.121-129 These methods include either changing the chemistry 
of collagen or adding a compound to SBF solutions. Even after these attempted 
modifications, the process appeared lengthy and the problem of the dissolution of 
collagen in the liquid medium posed a relevant issue. Therefore, our aim was to 
develop a biomimetically coating process that decreased the time to coat the 
collagen substrates (Chapter 7). 
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CHAPTER 2 
 
OSTEOBLAST PROLIFERATION ON NEAT AND APATITE-LIKE 
CALCIUM PHOSPHATE-COATED TITANIUM FOAM SCAFFOLDS 
 
Abstract 
The biocompatibility and the load-bearing ability of lightweight titanium made it 
possible to be used as a biomaterial, especially in hip revision and fixation 
surgery. It was initially shown that sand-blasted or surface-roughened titanium 
implants had an improved bone-bonding ability over the bioinert metallic 
surfaces. Plasma-spraying of a phase mixture of loosely-attached calcium 
phosphates on titanium implants further improved their in vivo bone-bonding 
ability. However, stoichiometric calcium hydroxyapatite ceramic of high 
crystallinity is known to have poor in vivo resorbability, and is shy of taking part 
in bone remodeling and of being resorbed by the osteoclasts. Supersaturated 
calcium phosphate (CaP) solutions, such as synthetic body fluids (SBF), on the 
other hand, are able to form “carbonated, hydrophilic and apatite-like” CaP nano-
aggregates on titanium surfaces. A Tris-buffered SBF solution with an HCO3− 
concentration of 27mM was used in this study. Neat, NaOH-etched, and SBF-
coated (biomimetic coating) titanium foams were compared with in vitro cell 
culture experiments by using rat osteoblasts. SBF-coated foams were found to 
yield the highest protein concentration at the end of the in vitro culture tests. Such 
biomimetic coatings were easily formed on flat strips, springs, or 3D foams of 
titanium, without any geometric constraints. The coated titanium springs and 
foams were characterized by using XRD, SEM, and FTIR. 
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2.1. Introduction 
Human blood plasma has a Ca/P molar ratio of 2.50. On the other hand, 
the same molar ratio becomes 1.556, 1.316×10−3, and 5.20 for the human 
extracellular, intracellular, and cerebrospinal fluids, respectively.1 Acellular SBF 
(synthetic body fluid) solutions try to mimic the ionic concentrations of human 
blood plasma, therefore, SBF is supersaturated with respect to the precipitation of 
carbonated, non-stoichiometric, poorly-crystallized or nanocrystalline apatite-like 
calcium phosphate.2,3 Ringer's4, Earle's (EBSS, Earle's Balanced Salt Solution5) 
and Hank's (HBSS6) solutions are most popular and are the guiding force for the 
development of synthetic body fluid solutions of today. In contrast to the earlier 
solutions, such as Ringer's, Earle's and Hanks solutions, the pH values of SBF 
solutions were fixed at the physiological value of 7.4 by using organic buffers, 
such as TRIS (tris-hydroxymethyl-aminomethane)2,3 or HEPES (2-(4-(2-
hydroxyethyl)-1-piperazinyl)ethane sulphonic acid)7–9.  
c-SBF2 was essentially a TRIS–HCl-buffered variant of HBSS6. c-SBF 
formulation raised the Ca/P molar ratio to 2.50, in comparison to 1.62 in HBSS. 
Moreover, HBSS and c-SBF solutions have exactly the same low carbonate ion 
concentrations (i.e., 4.2mM), which is far from imitating that of the human 
plasma (i.e., 27mM). Tas et al.3,10 have been the first to raise the HCO3− 
concentration in a TRIS–HClbuffered SBF solution (i.e., tas-SBF) to 27 mM, 
while Bigi et al.7 were the first to do the same in a HEPES–NaOH-buffered SBF 
solution (i.e., Bigi-SBF) of 27mM HCO3−. SBF solutions were found to be able to 
induce apatite-like calcium phosphate formation on numerous metallic, ceramic or 
polymeric surfaces (only after proper surface pretreatments) immersed in them.11 
Oyane et al.9, who developed the HEPES-buffered r-SBF recipe with ion 
concentrations exactly equal to those of human plasma, reported that r-SBF would 
release CO2 gas from the fluid, causing a decrease in HCO3− concentration, and 
an increase in pH value, when the storage period was long. Furthermore, these 
authors stated that r-SBF would not be suitable for long-term use in the 
biomimetic coating processes owing to its instability.9 The buffering agent TRIS 
present in conventional SBF (c- and tas-SBF) formulations, for instance, was 
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reported12 to form soluble complexes with several cations, including Ca2+, which 
further reduces the concentration of free Ca2+ ions available for the real time 
calcium phosphate coating. To our knowledge, this behavior has not yet been 
reported for HEPES.  
The term biomimetic coating stands for the formation of several micron-
thick layer of hydrated calcium phosphate nano-aggregates on any suitable 
substrate (either metallic, ceramic or polymeric) at the human body temperature 
(36.5–37°C) from a supersaturated or metastable solution, whose ionic 
composition and pH value mimic those of human plasma. As implied by this 
definition, the coating process shall not necessarily be instantaneous and may 
progress within the long physiological timeframes as well. Calcium phosphate 
deposits observed on explanted intraocular lenses13, silicon mammary 
prostheses14, and heart valves and arteries15 do all form in vivo working examples 
of natural biomimetic coating or calcification processes. In stark contrast to what 
numerous researchers keep naming in the open literature, the calcium phosphate 
aggregates deposited by the biomimetic coating processes are not simply calcium 
hydroxyapatite (HA: Ca10(PO4)6(OH)2 = 3 Ca3(PO4)2·Ca(OH)2). Biomimetic 
coating processes do not have the high enough pH to form a hydroxide material. 
Biomimetic coating deposits contain Ca2+, HPO42−, and PO43− ions, but the Ca/P 
molar ratio of those were found to be greater than 1.7, typically between 1.7 and 
2.7.16 Moreover, biomimetic CaP deposits were found to lack OH− ions like the 
human bones,17 and contain CO32− ions (between 19 and 40 wt.%)16. 
Characteristic micro-globules or spherulites deposited by the biomimetic coating 
consist of intermingling nanoplatelets of CaP resembling a porcupine architecture 
with high surface area. The thickness of the formed biomimetic coating 
nanoplatelets is very much comparable with that of the apatite-like nanocrystals 
(20–30nm) observed in bone mineral.18 Biomimetic coating surfaces represent a 
microtopographical complexity, which create a greater surface area to which bone 
cell-mediated proteins could adsorb.19 Therefore, the deposits obtained by the 
biomimetic coating are best described by using the following; “carbonated, 
hydrated, apatite-like calcium phosphate nanoplatelet aggregates.” Characteristic 
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nanotexture of such biomimetic CaP deposits on Ti6Al4V has been documented 
in the open literature.20,21 Regardless of the concentration of the SBF solution 
used, whether it is 1×SBF2,3 or 10×SBF21, the unique nanomorphology observed 
in the deposited layers did not change. Habibovic et al.22 coated Ti6Al4V foams 
(produced by polyurethane sponge-burn out method) in 3 days by using a TRIS- 
or HEPES-free 5×SBF (i.e., a solution five times more concentrated than c-SBF 
recipe) solution, and reported that when the CaP-coated foams were implanted 
into the back muscles of goats, they caused ectopic bone formation in 6 to 12 
weeks. Tas-SBF solutions with an HCO3− concentration of 27mM are able to coat 
titanium strips more quickly than c-SBF solutions23. The goal of this study was to 
test the rat osteoblast attachment and proliferation on surfaces of approximately 
85% porous (with interconnected pore sizes in the range of 400 to 500µm) 
titanium foams. Neat, NaOH-treated (60°C, 24h) and SBF-soaked (37°C, 7 days) 
titanium foam samples were prepared and the cell culture tests were performed on 
those in a comparative manner. Synthetic body fluid used in this study was a 
TRIS-buffered Tas-SBF solution of 27mM HCO3− concentration. 
 
2.2.  Experimental Procedure 
2.2.1.  Substrate preparation. Titanium foam pieces (Selee Corp., 
Hendersonville, NC), with dimensions of 10×10×1.25mm, were used as substrates 
in biomimetic coating. The foam pieces were washed, respectively, with acetone, 
ethanol and deionized water in an ultrasonic bath, followed by immersion in 
50mL of a 5M NaOH solution at 60°C for 24h in sealed glass bottles. After alkali 
treatment, each foam piece was washed with an ample supply of water. In-house 
Ti6Al4V springs were prepared as follows; an approximately 1-mm-thick and 7-
cm-long strip was first cut from a Ti6Al4V sheet, and then coiled around a steel 
rod (diameter 6mm) to form the spiral/spring shape. Such spring-like samples 
were used to evaluate the efficiency of the 3D surface coverage of the biomimetic 
coating process.  
2.2.2.  SBF solution preparation. SBF solutions were prepared according to the 
detailed protocol given elsewhere.3,10 The basic SBF recipe was hereby 
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concentrated by 1.5 times, therefore, the solutions used in this study were named 
as 1.5×Tas-SBF. Reagent-grade chemicals (all from Fisher Scientific, NJ) were 
used in preparing the solutions; NaCl (>99.0%), NaHCO3 (>99.7%), KCl 
(>99.5%), Na2HPO4 (>99.0%), MgCl2·6H2O (>99.5%), Na2SO4 (>99.0%), 
(CH2OH)3CNH2 (>99.8%), CaCl2·2H2O (>99.5%) and HCl (37vol.%). 20mg/L 
Na-azide was also added to the solutions to prevent bacteria growth. When not in 
use, SBF solutions were stored in glass jars in a domestic refrigerator at 4°C. 
2.2.3. Coating process. The springs or foams were soaked in 100mL of 1.5 × 
tas-SBF solutions kept at 37°C in sealed Pyrex® bottles of 100-mL capacity for a 
period of 7days. SBF solutions were completely replenished with fresh solutions 
every 48h. Prior to replenishment, fresh SBF solutions of pH 7.4 were heated to 
37°C. At the end of 7days of soaking, samples were removed from the SBF 
solutions, followed by washing first with 100mL of deionized water and then with 
10mL of 98% pure ethanol.  
2.2.4. Sample characterization. For phase analysis, the surfaces of the uncoated 
and coated foams were investigated by an X-ray diffractometer (XRD; Model 
XDS 2000, Scintag Corp., Sunnyvale, CA), operated at 40kV and 30mA with 
monochromated Cu Kα radiation. The foams were also analyzed by using 
Fourier-transformed infrared spectroscopy (FTIR; Nicolet 550, Thermo-Nicolet, 
Woburn, MA). FTIR was equipped with an Endurance Foundation Series single-
bounce diamond ATR (50° incidence angle) and 32 scans were collected at a 
resolution of 4cm−1. Scanning electron microscopy (FESEM; S4700, Hitachi 
Corp., Tokyo, Japan) was used to monitor the changes in the surface morphology 
of the foams before and after SBF-soaking. 
2.2.5. Cell culture. 7F2 rat osteoblast cells (CRL-12557, American Type Culture 
Collection, Rockville, MD) were grown in 75cm2 culture flasks at 37°C and 5% 
CO2 in an alpha-minimum essential medium (α-MEM, Sigma Inc.) with 2mM 1-
glutamine and 1mM sodium pyruvate, without ribonucleosides and 
deoxyribonucleosides, augmented with 10% FBS. The culture medium was 
changed every other day until the cells reached a confluence of 90–95%, as 
determined visually with an inverted microscope. The cells then were passaged 
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using trypsin (2.5 g/L)/EDTA (25mM) solution (Sigma). Obtained cells were then 
seeded at a concentration of 5000cells/well on 1cm2 samples for the various 
assays. Two control samples were used, one was the pristine foam and the second 
was the alkali-treated foam. Cell viability was assessed after 72h, and total protein 
amount was measured after 7days in a 24-well cell culture plate. Further details of 
the cell culture procedures were given elsewhere.23 Cell attachment studies were 
also performed on the foams by visual observation via FESEM. Prior to FESEM 
investigations, cells were fixed by using 3.5% glutaraldehyde. Osteoblasts were 
dehydrated through sequential washings in 50%, 75%, 95% ethanol solutions and 
2 times with 100% ethanol. Samples were then critical point-dried. Samples were 
sputter-coated with a thin layer of Pt prior to the FESEM observations performed 
at 5kV. For statistics, all experiments were performed in triplicate, where n=3.  
 
2.3. Results and Discussion 
The pore sizes (400 to 500µm) and strut morphology of the as-received 
titanium foams were depicted in Figure 2.1a. These foams have been produced 
using the polymeric sponge impregnation method with titanium powders. The 
high magnification inset in Figure 2.1a showed the characteristic kinks and steps 
of recrystallization phenomenon which took place during the sintering of the foam 
precursors. However, the NaOH-treatment of those foams completely removed 
those kinks and replaced the surface with nanoporous hydrated Na-titanate 
phase(s) as shown in Figure 2.1b. Hydrated Na-titanate layers on Ti with a 
slightly basic surface were believed to further enhance the biomimetic coating 
process.20 SEM photomicrographs of Figure 2.2 showed that the foams were fully 
covered with apatite-like calcium phosphates; consisting of micron-size CaP 
globules with nanoporous surfaces. FTIR data (not shown) of the TRIS-buffered, 
27mM HCO3− SBF-soaked (7 days) foam samples showed that all the coatings 
consisted of carbonated (CO32− ion absorption bands seen at 1470–1420 and 
875cm−1) calcium phosphates. The absence of the stretching and the vibrational 
modes of the O–H group at 3571 and 639cm−1 confirmed that these coatings 
might not simply be named as hydroxyapatite. We prefer to call them as 
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Fig. 2.1 SEM micrographs of Ti foams prior to SBF-soaking; (a) neat surface, (b 
NaOH-treated surface. 
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Fig. 2.2 (a–d) SEM micrographs of 27mM HCO3-Tris-SBF-coated (7days) 
titanium foams at various magnifications; characteristic CaP globules (c) 
and their nano-porous texture (d) were readily visible. 
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carbonated, apatite-like CaP. Micrographs of the SBF-coated titanium springs are 
given in Figure 2.3. 
SEM micrographs given in Figures 2.4, 2.5, and 2.6 depicted the 
osteoblast proliferation and attachment on neat titanium foams, NaOH-treated 
foams and the SBF-coated foams, respectively. In vitro cell culture results given 
in Figure 2.7 revealed that all three groups of samples were statistically and 
strikingly different from one another, and the cytotoxicity of the NaOH-treated 
samples was found to be the highest (Fig. 2.7a). In the specific comparison of 
pristine titanium foams with those treated in NaOH, it was evident that the former 
performed much better, which meant that the surface roughness or nano-
topography (or nanotexture) was not a sole factor in determining the advance of 
osteoblast attachment, spreading and proliferation. Here the surface chemistry 
strongly prevailed in the sense that the neat, nonporous, low surface area titanium 
foams turned out to be less cytotoxic than high surface area, nano-porous, NaOH-
treated foams with a surface layer of hydrated, basic Na-titanates.20  
SBF-coated titanium foams, on the other hand, were found to have the 
highest protein concentration and cell viability levels (Fig. 2.7). While in the case 
of neat titanium foams the osteoblasts were only able to attach and then extend 
their filopodia over the available surface (Figure 2.4c and d), the osteoblast cells 
on SBF-coated foams were able to proliferate to the extent that even the vinculin 
adhesion plaques and the actin cytoskeleton and stress fibers became visible (Fig. 
2.6d). Throughout its cell culture tests, this study concurrently investigated the 
same titanium foam material with three different surfaces, i.e., neat, NaOH-
treated, and apatite-like CaP deposited from an SBF solution. The response of 
osteoblasts to a given surface can be regarded as the sum of their ability to attach, 
proliferate, and differentiate. In the attachment stage, osteoblast filopodia 
explored the substrate topography (Fig. 2.4) for areas to which a greater surface 
area of the cell can adhere. These filopodia were used in sensing the substrate, and 
they extended over significant distances to find areas appropriate for attachment. 
As was the case with NaOH treated titanium foams, cells were seen to produce 
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Fig. 2.3  SEM micrographs of 27mM HCO3- Tris-SBF-coated (7 days) titanium 
springs/spirals. 
 
   
 
   
 
Fig. 2.4  Osteoblast proliferation and attachment on neat titanium foam surfaces. 
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Fig. 2.5 Osteoblast proliferation and attachment on NaOH-treated titanium 
foams. 
 
   
 
   
 
Fig. 2.6  Osteoblast proliferation and attachment on 27mM HCO3-Tris-SBF-
coated titanium foams. 
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Fig. 2.7  In vitro (a) cell viability and (b) protein concentration histograms for the 
samples of Figures 2.4–2.6. 
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fewer adhesion plaques while still in the process of migration than ones 
permanently settled in place (Fig. 2.5). SEM micrographs given in Figures 2.4b, 
2.5b, and 2.6b alone can also be used as a concise visual comparison tool for the 
osteoblast proliferation behavior on three different titanium surfaces of this study.  
How does biomimetic coating proceed via SBF solutions? If a simple 
aqueous solution, which only contains 2.5mM CaCl2·H2O dissolved in it, is 
exposed to a gaseous CO2 atmosphere, it will start precipitating submicron 
particles of CaCO3 (calcite and/or vaterite) within the following few hours of 
ageing at room temperature.24 CO2 gas leads initially to the formation of carbonic 
acid, H2CO3, and it will dissociate into HCO3− and CO32− aqueous species. The 
reversal of these dissociation reactions will cause the release of CO2 gas out of the 
solution, with an accompanied increase  in the pH value. The HCO3−/CO32− pair 
exerts a buffering effect. However, if one adds 27mM NaHCO3 to this Ca-
chloride solution, this will eliminate the necessity of exposing it to a gaseous CO2 
atmosphere, and again, it would only form submicron CaCO3 precipitates.25 If one 
adds 1mM Na2HPO4 into the above carbonated Ca-chloride solution (Ca/P=2.50) 
together with 112mM NaCl, this solution of ionic strength of 149.5mM will 
precipitate carbonated calcium phosphates instead of pure CaCO3. This solution is 
saturated with respect to the formation of apatite-like calcium phosphates, and it 
contains Ca2+, HPO42−, HCO3−, Na+, and Cl− ions. The main question here is 
whether the resultant precipitates still contain CaCO3 at their cores or not. Does 
the precipitation proceed by a topotactic reaction of heavily carbonated CaP 
growing on CaCO3 (vaterite perhaps) particles? These questions must be 
addressed prior to calling the SBF deposited CaP layers simply as 
“hydroxyapatite.” When the pH of the above solution is brought down to the 
range of 5 to 6, for instance, by adding tiny droplets of dilute HCl, it will only 
precipitate CaHPO4·2H2O (i.e., brushite, DCPD, dicalcium phosphate dihydrate). 
If the pH value of that solution is kept at the physiological value of 7.4 or higher, 
it would nucleate carbonated, apatite-like calcium phosphates. Over the pH range 
of 6.2 to 10, HCO3− is the most stable carbonate species in aqueous solutions. The 
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precipitation of carbonated, apatite-like calcium phosphates from such a solution 
may be described by using the following reaction26: 
According to the above B-type substitution scheme (which is typically 
observed for low-temperature apatites) of Eq. (1), HPO42− and CO32− ions replace 
the PO43− tetrahedra. The charge imbalance created by these substitutions will be 
compensated by the Ca-vacancies. Monovalent Na+ ions will also substitute over 
a certain fraction of the Ca-sites. Bone mineral, with extremely small sizes of 
biological apatite-like crystals (i.e., 20 to 30nm), contains substantial amounts of 
CO32− (4 to 6 wt.%), 0.5% Mg2+, 0.7% Na+, is about 10% Ca-deficient with the 
accompanying increase in reactivity related to this condition27, and moreover, the 
presence of HCO3− in aqueous environments is known to reduce the apatitic 
growth rate28. As seen from Eq. (1), precipitation of apatite-like calcium 
phosphates may also be accompanied by a slight pH decrease. All the precipitated 
calcium phosphate powders, therefore, may possess, to a certain extent, Ca-
deficiency, HPO42− and CO32− ions in their nanocrystalline moieties. Carbonate 
ion doping into the phosphate tetrahedra of apatite-like calcium phosphates will 
result in the creation of charge compensating Ca-vacancies, and this is the reason 
for the observed Ca-deficiency of CaPs synthesized in body fluids.10,29 Astala and 
Stott29, based on their electron density function calculations, recently reported that 
CO32− ions and the Ca-vacancies are strongly related with one another and form a 
cluster complex in the crystallographic unit cell of apatite-like calcium 
phosphates. 
The addition of 5mM K+ and/or 0.5mM SO42− ions (since these ions are 
present in the human blood plasma) into a solution as described above do not 
change the nature of the precipitates formed. Increasing the amount of Na+ and 
Cl− ions to the levels present in human blood plasma (i.e., 142 and 103mM, 
respectively) would just increase the ionic strength of the new solution. For 
instance, the ionic strength of the Tas-SBF (27mM HCO3- Tris-buffered) used in 
this study is 160.5mM. Theoretically, if a solution has a low ionic strength, this 
means that the ionic diffusion will be enhanced in such a solution. Therefore, in a 
solution of low ionic strength and high ionic diffusion, there will be more 
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nucleation sites for the precipitation reactions. CO2 would be released from an 
aqueous solution at a faster rate if the solution has a low ionic strength.30 The 
presence of NaCl in human blood plasma is for the purpose of fixing the ionic 
strength at the value of 149.5mM. If one increases the ionic strength of an SBF 
solution to above 1100mM, its rate of CO2 release would be slowed down 
significantly.21 If one adds 1.5mM Mg2+ into the above solution, this would slow 
down the growth rate of apatitic calcium phosphates, and also favor the formation 
of poorly-crystallized (i.e., in terms of their XRD spectra—not shown here), non-
stoichiometric calcium phosphates.16 Mg is, therefore, an important additive in 
SBF solutions and chemically incorporated into the SBF-formed CaP 
precipitates.16  
Yin and Stott31 pointed out that an amorphous calcium phosphate (ACP) 
precursor would always be present during the precipitation of apatite-like calcium 
phosphates from highly supersaturated solutions, such as the SBF solutions used 
here. Posner and Betts27 proposed that the process of ACP formation in solution 
involved the formation first of Ca9(PO4)6 clusters which then aggregated 
randomly to produce the larger spherical particles or globules (Figs. 2.2 and 2.6), 
while the intercluster space is being filled with water. Such clusters (with a 
diameter of about 0.95nm31) were the transient solution precursors to the 
formation of carbonated apatite-like calcium phosphate precipitates as described 
in Eq. (1) above. The passage from the angstrom-size Posner's clusters in solution 
to the solid nanoaggregates of carbonated-CDHA (i.e., Ca9(PO4)5-CO3OH) or 
dahllite (Ca10(PO4)6CO3=3Ca3(PO4)2·CaCO3) or a solid solution of those should 
be the key concept of biomimetic coating by the use of SBF or supersaturated CaP 
calcification solutions (SCS). One proton to be released by the aqueous 
bicarbonate ion (i.e., HCO3−→CO32− + H+) can readily be consumed in forming 
the hydrogen phosphate groups of CDHA. c-SBF solutions (which are similar to 
the HBBS solution in terms of ionic concentrations) of low HCO3− concentration 
(4.2mM) are slow in forming CDHA in comparison to Tas-SBF of 27mM HCO3−. 
c-SBF solutions require more than 2weeks (typically 3weeks) to completely cover 
a given titanium surface.2,8,11,20 If the formation of dahllite or a precursor phase 
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like that is indeed required, then the sluggish response of c-SBF solutions 
becomes understandable. The concentration of the carbonate ions in synthetic 
body fluid formulations does significantly influence the advance of the 
biomimetic coating process. Onuma and Ito32 have demonstrated, by using 
dynamic light scattering, the presence of such calcium phosphate clusters from 
0.7 to 1.0nm in size in transparent-looking synthetic body fluids. They reported 
that calcium phosphate clusters were present in SBF even when there was no 
precipitation. This was true after 5 months of storage at RT. Since these 
nanoclusters are always present even in supersaturated SBF solutions, the 
insertion of, for instance, a suitable alkali solution-treated titanium surface into 
the solutions triggers the hexagonal packing32 of those nanoclusters to form 
apatite-like CaP aggregates.  
ACP can also be present together with the nanocrystalline apatite-like 
CaP, as confirmed by the previous TEM studies performed on the SBF-coating 
layers.33 The role of alkali-treated Ti6Al4V surfaces in stimulating the SBF-
coating process has been explained in great detail by Kokubo et al.11,20 
Continuation of this phase separation process from the SBF solutions will be 
conditional upon the smooth supply of Ca2+, HPO42− and CO3− ions to the metal-
solution interface. These colloidal precipitates (as a result of the hexagonal 
packing of the nanoclusters32) are formed by a homogeneous nucleation and 
precipitation process. The presence of these initial precipitates within the solution 
further accelerates the coarsening of the micron-sized calcium phosphate globules 
(see Figs. 2c, 3c and 6c). Precipitation observed in SBF solutions is closely 
related to the HCO3− (aq) concentration. A certain fraction of dissolved carbonate 
ions will be lost as CO2 (g), followed by an increase in solution pH to above 7.5, 
and then this loss would decrease the level of supersaturation of the solution.34 
This explains the lesser amount of coating formed on titanium surfaces when the 
solutions were not replenished, let us say, for 1week. TRIS-buffered SBF 
solutions (1.5SBF) of 27mM HCO3− concentration were able to form those 
substratebound precipitates by the end of 2nd day of soaking at 37°C. However, 
when the HCO3− concentration was lower (i.e., 4.2mM; c-SBF) in the SBF, the 
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rate of formation of these precipitates is decreased. Since the Ca/P molar ratio of 
the SBF solutions were 2.50, they are not stable against carbonated, apatite-like 
CaP, dahllite or OCP (octacalcium phosphate; Ca8(HPO4)2(PO4)4·5H2O) 
precipitation when the solution pH is higher than 6.3.16,35 On the other hand, OCP 
typically forms, in comparison to CDHA, carbonated-CDHA or dahllite, at 
slightly lower pH values and much lower Ca/P molar ratios36. It should be noted 
that since the crystallinity of such hydrated and hydrophilic biomimetic coatings 
is extremely poor, it may be rather difficult to distinguish and quantify (e.g., by 
XRD) the amounts of mixed apatite-like CaP, dahllite and OCP phases in the 
deposited layers.37 Dorozhkina and Dorozhkin16 determined the water and 
carbonate contents of SBF-formed precipitates to be 10 and 15 wt.%, respectively. 
With the advance of precipitate formation the inherent level of supersaturation in 
the solution decreases, eventually the CaP nanoaggregate formation comes to a 
halt, and hence this is where one would need replenishing the SBF solution. If one 
does not replenish the SBF solution used in biomimetic coating for more than 
several days or 1week, then due to the abovementioned loss in supersaturation 
and as exemplified by Iimori et al.38, one would start seeing the deposition of 
calcite (CaCO3) crystals. However, CaCO3 (nacre, aragonite, vaterite and calcite) 
is one of the mostly preferred and biocompatible materials used by mother nature 
in aquatic life forms.  
 
2.4. Conclusions 
Titanium foams with interconnected pores were coated biomimetically 
with apatite-like calcium phosphates in 7 days by using TRIS-buffered, 27mM 
HCO3− containing 1.5×Tas-SBF solution. Titanium springs/spirals were also 
coated with the same solution. Biomimetic coating process was able to cover all 
the surfaces and struts of the samples. In vitro cell culture tests with rat 
osteoblasts were used to compare the neat, NaOH-treated and SBF-coated 
surfaces of titanium foams. In terms of osteoblast attachment, protein production 
and cell proliferation, NaOH-treated surface has the least amount of cells 
attached, whereas the SBF-coated surfaces had the most. Untreated, neat titanium 
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foam surfaces were found to be less cytotoxic to the osteoblasts in comparison to 
NaOH-treated titanium surfaces. Of the three surfaces compared, SBF-coated 
surfaces exhibited the highest protein production and cell attachment figures. 
Biomimetic coating is a practical and robust way of increasing the 
biocompatibility of titanium foams or spring-like shapes by coating them with 
bone-like, carbonated, nanotextured apatite-like calcium phosphates.  
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CHAPTER 3 
 
A PROTOCOL TO DEVELOP CRACK-FREE BIOMIMETIC COATINGS 
ON Ti6Al4V SUBSTRATES 
 
Abstract 
Biomimetic coating of titanium and related alloys with carbonated apatitic 
calcium phosphate is an important area of research in implantology. One step in 
the protocol involves an intermediate alkali treatment of Ti6Al4V to form a 
sodium titanate layer on the alloy surface. This pre-treatment enhances the 
formation of the coating from simulated body fluid (SBF) solutions. Many papers 
in the biomimetic coating literature demonstrate presence of cracks in coatings, 
irrespective of the SBF compositions, and placement of the substrates. The 
presence of cracks may result in degradation and delamination of coatings.  To the 
best of our knowledge, this issue remains unresolved. Therefore, the aim of this 
study was: (1) to examine and understand the reasons for cracking and (2) based 
on the results, to develop a protocol for producing crack-free apatitic calcium 
phosphate coatings on Ti6Al4V substrates. In this study, the authors focused their 
attention to the alkali treatment procedure and the final drying step. It is 
hypothesized that these two steps of the process affect the crack formation the 
most. In the first case, the surfaces of alkali treated substrates were examined 
with/without water soaking treatment before immersing in SBF. This water 
treatment modifies the sodium titanate surface layer. In the second case, two 
different drying techniques (after soaking in SBF) were employed. In one 
procedure, the coated substrates were dried rapidly and in the other, they were 
dried slowly. It was observed that the water treatment, irrespective of the drying 
method, provides a surface, which on subsequent soaking in SBF forms a crack-
free apatitic calcium phosphate coating. Based on these results, we suggest a 
protocol incorporating a water soaking treatment after the alkali treatment and 
prior to the SBF soaking treatment to obtain crack-free coatings.    
(This work is in print in J Mater Res 22 (Jun 2007)
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3.1 Introduction 
Coating carbonated apatitic calcium phosphate layer on titanium and its 
alloys has been of increasing interest due to their ability to directly bond with 
bone.1,2 Of the many coating processes available today, the biomimetic coating 
technique has many advantages including producing carbonated apatitic calcium 
phosphate coatings, which is otherwise impossible to produce. The coatings are 
formed by soaking an alkali pre-treated titanium (or an alloy) substrate in a 
simulated body fluid (SBF) solution.3-6 The alkali pre-treatment is a crucial step, 
which forms a hydrous sodium or potassium titanate layer (depending upon the 
alkali used) on the substrate.3-6 The as-formed sodium (or potassium) titanate on 
soaking in SBF exchanges Na+ (K+) ions with the H3O+ ions and forms Ti-OH 
groups on the surface that increases the ionic activity of apatite in SBF.7 During 
soaking, nanometer sized apatitic calcium phosphate globules rapidly nucleate on 
the sodium (or potassium) titanate layer and then grow to a few microns by 
consuming Ca and P ions from the SBF solution.4  
In spite of all the advantages of the biomimetic coating process, the 
phenomenon of cracking persists. Furthermore, the reason for cracking of such 
coatings remains unresolved. The present paper is an attempt to examine this 
issue. Previously, the present authors investigated the apatite inducing abilities of 
different SBF solutions referred to as c-SBF, t-SBF and r-SBF on these alkali 
treated titanium substrates.8 c-9 and r-SBF10,11 are conventional and revised 
versions of SBF, as developed by Kokubo. t-SBF is the formulation developed by 
Tas12,13.  The compositions of the three SBF solutions and the important 
differences between them are given in ref 8. The authors noted that cracks were 
persistently present on these apatitic calcium phosphate coating irrespective of the 
composition of the coating solution.8 Also, the placement of the substrates (e.g., 
horizontal or vertical) was examined as a parameter affecting the formation of 
cracks in the coatings.8 These cracks were present on all the substrates 
irrespective of their placements.8 A major consequence of the presence of these 
cracks substantially increases the chances of delamination. Thereby, decreasing 
the coating’s bonding ability with the natural bone.  
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The SEM micrographs, as reported by the present authors8 and other 
researchers14-22 indicate that these cracks are not just surface cracks and are rather 
deep. However, in the references14-20, the authors did not mention the cause of 
these deep cracks. In other papers, drying is cited as a potential reason for their 
formation.6,8,21,22 The main reason for this argument is that the water entrapped 
does not readily escape during low temperature drying and leads to deep 
cracks.6,8,21,22 It is known that in the SBF solution, Posner’s clusters are the 
dominant transient phase during the formation of calcium deficient carbonated 
calcium phosphates.23,24,25 Since Posner’s clusters already have water molecules 
in their intercluster spaces, the aggregates of these clusters forming the nano-
porous coating layers on Ti6Al4V surfaces also entrap a sizable amount of 
water.23,24,25 Yet another explanation is attributed to the presence of thermal 
expansion coefficient mismatch between the Ti6Al4V substrates and the calcium 
phosphate coating layers.26 Most of these explanations are hypothetical in nature 
and are not based on concrete experimental results.  
The broad objective of the present work was to find the reasons for the 
formation of such cracks and to establish a protocol for producing crack-free 
homogeneous biomimetic coating on Ti6Al4V utilizing t-SBF. The reasons for 
using t-SBF are given in ref. 8. Since the cracks appear to be deep, the authors 
hypothesize that the hydrous sodium titanate layer4 formed on the Ti6A14V 
substrate has a role in the formation of cracks in the coatings. Thus in this careful 
study, we modified the pre-treatment procedure and subsequently examined its 
effect on formation of cracks in the coatings. Also, we attempted new drying 
procedures to examine the effect of drying on the crack formation. The rate of 
removal of water differentiates the new and the conventionally used procedures. 
The new procedure leads to the rapid removal of water as compared to the 
conventional method, in which the entrapped water does not readily escape.  
 
3.2 Experimental Procedure 
3.2.1  Substrate Preparation and Alkali Pre-treatment. Ti6Al4V strips (Grade 
5, McMaster-Carr), with the dimensions of 10 x 10 x 1 mm, were used as 
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substrates in the SBF coating. The substrates were first abraded with a #100 SiC 
paper (FEPA P#1000, Struers) and then washed three times respectively with 
acetone, ethanol, and deionized water in an ultrasonic bath. Each substrate was 
then immersed in 50 mL of 5M NaOH solution at 60ºC for 24 hours. At the end of 
this alkali treatment, substrates were given two different treatments to check the 
effect on change of composition of treated layer on coating cracks. The first 
treatment involved the most commonly used practice of drying the substrates at 
40ºC for 24 hours after alkali treatment. The second treatment consisted of 
immersing the substrates in water at RT for 24 hours after the alkali treatment and 
then drying them at 40ºC for 24 hours. 
3.2.2 SBF Solution Preparation. The details of SBF preparation routines are 
given in Table 3.1. Freshly prepared t-SBF solution12,13 was used in coating 
experiments. We concentrated the basic SBF recipe by 1.5 times, as per common 
practice in the biomimetic coating of Ti6Al4V. The order of addition of the 
reagents to 700 mL of water is given in the second column of Table 3.1. A total of 
65 mL of 1M HCl was consumed for pH adjustments during the preparation of 1 l 
of 1.5 x t-SBF solution. A 15 mL aliquot of this acid solution was added just 
before the addition of the sixth reagent, CaCl2.2H2O. Otherwise, the solution 
would display slight turbidity. The remaining part of the HCl solution was used 
during the subsequent titration. Following the addition of the eighth reagent, 
tris(hydroxymethyl) aminomethane, the solution temperature was raised from  
 
 
Table 3.1 Preparation of t-SBF solution (1 L)12,13 
 
    Reagent  Weight (g) Ion Human Plasma(mM)     SBF (mM) 
    NaCl   6.547  Na+  142         142 
    NaHCO3  2.268  Cl-  103         125 
    KCl   0.373  HCO3-  27           27 
   Na2HPO4⋅2H2O 0.178  K+  5          5.0 
   MgCl2⋅6H2O  0.305  Mg2+  1.5          1.5 
   CaCl2⋅2H2O  0.368  Ca2+  2.5          2.5 
   Na2SO4  0.071  HPO42-  1          1.0 
   (CH2OH)3CNH2 6.057  SO42-  0.5          0.5 
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ambient temperature to 37ºC. This solution was then titrated with 1 M HCl to a 
pH of 7.4 at 37ºC. During the titration process, the solution was also continuously 
diluted with consecutive additions of deionised water to make the final volume 
equal to 1 l. 
3.2.3 Coating and Drying Process. For coating purposes, the pre-treated 
substrates were soaked vertically in 100 mL of t-SBF at 37ºC in tightly sealed 
Pyrex bottles of 100 mL capacity for a period of 7 days. The reason for using 
vertical placement (by hanging in the solution bottle via a stainless steel wire) is 
given in ref. 7. The SBF solution was replenished at every 48 hours. Prior to 
replenishment, fresh SBF solutions of pH 7.4 were heated to 37ºC. The substrates 
were removed from the SBF solution followed by gentle washing with 
approximately 100 mL deionized water and then dried using two different 
techniques. The first technique involved the commonly used method for drying 
the biomimetically coated substrates that is, drying the substrates at 40 º C for 24 
hours. The second technique involved water soaking, followed by rinsing with 50 
mL of 99.5% ethanol and then placing the substrates at RT for 15 minutes to 
evaporate ethanol. 
3.2.4 Sample Characterization. For phase analysis, the surfaces of the uncoated 
and coated substrates were investigated by X-Ray Diffraction (XDS 2000, Scintag 
Corp., CA) using monochromated Cu Kα radiation generated at a voltage and 
power of 40 kV and 30 mA, respectively. The substrates were also analyzed by 
using Fourier-transformed infrared spectroscopy (Nicolet 550, Thermo-Nicolet, 
MA). FTIR was equipped with an Endurance Foundation Series single-bounce 
diamond ATR (50º incidence angle) and 32 scans were performed at a resolution 
of 4 cm-1. In order to analyze the substrate surface, before and after every 
treatment for cracks, scanning electron microscope (FESEM, S-4700, Hitachi 
Corp., Tokyo, Japan) operated at 5 kV was used.  To determine the amount of 
sodium present in the surface layer, samples were characterized using inductively 
coupled plasma-atomic emission spectroscopy (ICP-AES, Model 61E, Thermo 
Electron, Madison, WI). 
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3.3 Results 
The results of this study are divided into two groups: a) an alkali pre-
treatment before soaking in SBF solution and b) a drying step after soaking in 
SBF solution.  
3.3.1 Alkali pre-treatment before soaking in SBF solution:  
After the alkali treatment, substrates were divided in two sets of samples; 
the first set was oven-dried at 40ºC for 24 hours and the second set was soaked in 
water and then oven-dried at 40ºC for 24 hours. After completing these 
procedures, the substrates were examined by XRD, FTIR, and SEM. Figure 3.1 
shows the XRD patterns of (a) as-received Ti6Al4V substrates; (b) substrates 
after polishing, NaOH-treatment, and drying at 40ºC for 24 hours; and (c) 
substrates after polishing, NaOH-treatment, water-treatment, and then drying at 
40ºC for 24 hours. Ti6Al4V readily forms titanium oxide (TiO2) layer on the 
surface on exposure to air. Prior to any treatment, titanium oxide was present on 
the as-received Ti6Al4V strips of this study as determined by the XRD pattern 
shown in Figure 3.1a. All rutile (TiO2) peaks are marked as (*) on the pattern. A 
hydrated layer of sodium titanate (marked as ^) and titanium oxide (Rutile, TiO2) 
was reported to form on the exposed surfaces of Ti6Al4V strips after 24 hours of 
immersion in a 5M NaOH solution at 60ºC.3,4,16 This layer was indeed found to be 
present on both NaOH treated and water treated Ti6Al4V strips. Both the patterns 
have similar peaks and respective intensities, and no significant difference was 
found in the XRD patterns (Figs. 3.1a and b). The FTIR pattern of NaOH-treated 
Ti6Al4V strips (Fig. 3.2b) shows that they were hydrated in nature with a huge 
band of H2O present from 3700-2400 cm-1 and one present at 1640 cm-1. Both of 
these bands were also present on the substrates after water treatment (Fig. 3.2c), 
thus, confirming their hydrated nature. The most important difference in the FTIR 
pattern was the presence of carbonates in the NaOH treated surface layer. FTIR 
pattern showed the presence of carbonate bands (CO32-) between 1470-1410 and 
at 870 cm-1 in the NaOH-treated substrates (Fig. 3.2b) whereas these bands were 
absent after water treatment (Fig. 3.2c) as shown. Inductively coupled plasma 
analyses showed significant differences in the amount Na present on the surface  
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Fig. 3.1  XRD pattern of (a) as-received Ti6Al4V, (b) 5M NaOH treated and then 
dried at 40ºC, and (c) 5M NaOH treated and then soaked in water (O: 
Titanium, *: Rutile, and ^: Sodium Titanate) 
 
 
Fig. 3.2 FTIR pattern of (a) as-received Ti6Al4V, (b) 5M NaOH treated and then 
dried at 40ºC, and (c) 5M NaOH treated and then soaked in water 
(arrows point the H2O and CO32- bands).  
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layer of the NaOH treated and water treated samples. As expected during water 
treatment, sodium was released from the substrate surface into the water in which 
they were immersed. The amount of Na present in the hydrous sodium titanate 
layer of NaOH-treated substrates was 8.25 wt.% whereas, in water treated 
substrates, the amount decreased to 3.6 wt.%. 
Examination of these differently treated substrates under the SEM also 
showed variations in microstructure. The alkali treatment, prior to soaking in SBF 
solution, provided the substrate with a certain nano-scale roughness as shown in 
the SEM micrographs of Figure 3.3a. The nano-porous structure formed by the 
NaOH treatment was unchanged after water treatment (Fig. 3.3b). But the water 
treatment had a considerable effect on the microstructure. The NaOH-treated 
substrates that were dried at 40ºC subsequently showed large number of cracks 
(Fig. 3.3a), which were persistent throughout the surface of the hydrated sodium 
titanate layer. These cracks might have formed during the drying process at 40ºC 
due to the release of either water or carbonates from the layer. However, cracks 
could not be seen in the low magnification micrographs (inset in Fig. 3.3), only in 
the high magnification micrographs, they (cracks) become detectable. In contrast, 
the water treated substrates were crack-free as shown in Figure 3.3b. To 
summarize, it is clear that water soaking after alkali treatment forms a hydrate 
sodium titanate layer without carbonates and cracks, and with a lower sodium 
content. All other features remain the same.  
3.3.2 Drying step after soaking in SBF solution:  
This section describes the results obtained after the alkali treated 
substrates (with/without water treatment) were soaked in 1.5 times t-SBF solution. 
Upon soaking, calcium phosphates covered the surface of these substrates within 
7 days (Fig. 3.4). The alkali treated substrates with/without water treatment after 
SBF coating were dried in two different methods to see the effect of kinetics of 
drying. One method was to dry the substrates by placing them at 40ºC for 24 
hour; and the other was to wash the coated substrates with ethanol and then dry 
them at room temperature. The former method is slower than the latter. Figure 
3.4a shows that the NaOH-treated substrate coated with apatitic calcium  
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Fig. 3.3 SEM micrographs of Ti6Al4V strips treated with 5M NaOH at 60ºC for 
24 hours then (a) dried at 40ºC for 24 hours, and (b) soaked in deionized 
water for 24 hours (inset shows low magnification view). 
 
 
      
                
Fig. 3.4  Substrates after alkali treatment dried at 40ºC for 24 hours, then soaked 
in t-SBF for 7 days and then (a) dried at 40ºC for 24 hours and (b) dried 
with ethanol. Substrates after alkali treatment were soaked in deionized 
water for 24 hours, soaked in t-SBF for 7 days, and then (c) dried at 
40ºC for 24 hours, and (d) dried with ethanol (inset shows low 
magnification view). 
  
 
52
phosphate developed deep cracks after drying it at 40ºC for 24 hours. Because 
these cracks have previously been referred to as “drying cracks”, or those formed 
while drying, the second method of drying was used. The SEM micrographs (Fig. 
3.4b) showed morphology and cracks similar to those shown in Figure 3.4a. Thus, 
this ethanol treatment was unsuccessful in removing the cracks from the coating 
surface. Figure 3.4c and d show the substrates that were water treated after alkali 
treatment and then soaked in SBF for 7 days. Subsequently, the substrates were 
washed with water and then dried at 40ºC for 24 hours (shown in Fig. 3.4c). The 
SEM micrographs at both high and low magnification (shown in inset) show a 
crack-free coating surface, and also showed no significant difference in the 
morphology of the apatitic calcium phosphate coatings. The micrograph depicts 
the round globules with needle-like intermingled nano-size calcium phosphates on 
the surface of Ti6Al4V strips. At the end of the soaking time, the substrates 
(shown in Fig. 3.4d) were first washed with water and then rinsed with ethanol. 
The micrograph is very similar to that in Figure 3.4c, which also shows a crack-
free apatitic calcium phosphate coating.  
The calcium phosphate coatings formed on substrates after different pre-
treatments retained a similar XRD pattern (Fig. 3.5). The broadening of the 211, 
112 and 300 reflections between 30-34º and the relatively high intensity of the 
002 reflection at 25.9º confirms the nano-nature and the low crystallinity of the 
coatings. The titanium peaks were still visible and these are marked as (*) in the 
XRD pattern (Fig. 3.5). FTIR patterns (Fig. 3.6) were also similar for all coated 
samples and showed that all the coatings consisted of carbonated, (CO32- ion 
absorption bands seen at 1470-1420 and 875 cm-1) calcium phosphates. The 
absence of the stretching and vibrational modes of the O-H group at 3571 and 639 
cm-1 confirmed that these coatings might not be simply termed as hydroxyapatite. 
These characteristics are similar to the coatings that we came across in our earlier 
experiments.8 Thus, the coatings retain all the expected characteristics but remain 
crack-free, when soaked in water after alkali treatment. 
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Fig. 3.5 XRD pattern of alkali treated Ti6Al4V soaked in 1.5x t-SBF for 7 days 
 
 
Fig. 3.6  FTIR pattern of alkali treated Ti6Al4V soaked in 1.5x t-SBF for 7 days 
  
 
54
3.4 Discussion 
 The deionized water, which normally has a neutral pH of 7.0, now has an 
acidic pH of approximately 5.7 when exposed to air. Carbon dioxide dissolves 
slightly in water to form carbonic acid, H2CO3, a weak acid, according to the 
following reaction: 
H2O + CO2 = H2CO3 
When sodium hydroxide is added to this deionized water, some of it reacts with 
the carbonic acid to form sodium bi-carbonate, as follows: 
H2CO3 + NaOH = NaHCO3 + H2O 
The pH of the solution is increased to 9. The bi-carbonate ion is relatively 
unstable in comparison to the carbonate ion at this pH. Thus, it leads to the 
formation of sodium carbonate, as per the following:  
NaHCO3 + NaOH = Na2CO3 + H2O 
Thus, the alkali solution now contains mostly NaOH with small amounts of 
dissolved Na2CO3. The mechanism of the reaction of the titanium alloy with this 
alkaline solution has been previously explained by Kokubo et al. 4. On soaking 
the substrates in alkali solution, the negatively charged hydrated titanate forms, 
with incorporated sodium ions in it.4 A hydrated layer of sodium titanate and 
titanium oxide has been reported to form on the exposed surfaces of Ti6Al4V 
strips after 24 hours of immersion in a 5M NaOH solution at 60ºC.3,4,16 The 
formation of this hydrous sodium titanate after alkali treatment was confirmed by 
the XRD pattern as shown in Figure 3.1. Since this solution contains small 
amounts of Na2CO3, it also plays a role in the etching process of the Ti6Al4V 
strips. There is a tendency to form either a compound containing carbonates in it 
or a complex with sodium titanate on the surface layer. Although no additional 
phase was detected by XRD, the presence of carbonates in the treated surface is 
confirmed by FTIR pattern as shown in Figure 3.2b. To summarize, it is clear that 
the surface layer of NaOH treated Ti6Al4V consists a mixture of hydrated, 
carbonated sodium titanate and titanium dioxide (rutile).  
 One possible explanation can be presented when the alkali treated 
substrates were immersed in deionized water for 24 hours at RT. The deionized 
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water has a pH of 5.7, at which carbonic acid is the most stable ion phase. On 
soaking the NaOH treated substrates in deionized water, there is a tendency for 
the CO32- ions present in the surface layer to react with the H+ ions of water and 
form carbonic acid, as follows:  
2H+ + CO32- = H2CO3. 
After 24 hours of soaking time, all the carbonates from the substrate surface go 
through the reaction. After drying, the substrate is a carbonate-free surface. This 
effect of carbonate release from the surface with water treatment is substantiated 
by the FTIR pattern shown in Figure 3.2c. Thus, the data presented in this study 
highlights differences in the compositions of surface layers after two different 
surface treatments. The data show that the substrates, before and after water 
treatment, differ in the (a) sodium, and (b) carbonate contents in the surface 
treated layer.  
 The water soaking treatment leads to a decrease in the amount of sodium 
in the alkali treated layer from 8.25 to 3.6 wt. %. In the present study, the water 
treatment was performed in large amounts of water for 24 hours at RT.  Though 
performing the water soaking treatment with a small quantity of water at RT for 1 
minute results in a decrease in the amount of sodium, it does not remove the 
carbonates from the surface. Jonasova et al.17 studied the effect of washing the 
alkali treated substrates with water at RT on their apatite inducing ability. No 
significant difference in the rate of apatite formation was observed but the Na 
amount was lowered from 9.6 to 3.5 at. %.17 When the water treatment is 
performed with large amounts of water for 48 hours at 80°C, Uchida et al.27 
observed an increase in apatite formation on titanium metal. However, this 
enhancement of the apatite forming ability is due to the formation of anatase, 
formed from the conversion of sodium titanate gel after water treatment at high 
temperatures.27 The decrease in sodium content in the surface layer did not cause 
this increase. Since we performed the water treatments at R.T., our results were in 
direct correlation to those obtained by Jonasova et al.17. SEM micrographs in 
Figure 3.4 show that the rate of apatite formation is similar on substrates with 
different Na content. XRD results (Fig. 3.1) confirm that the substrate surface 
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consists of rutile after water treatment at RT, instead of anatase as formed by 
Uchida et al.27 after water treatment at 80°C  
 In studies performed by Jonasova et al.17 and Uchida et al.27, cracks were 
persistently present in all the biomimetically deposited coatings. These findings 
show that the presence of different sodium content in the surface layer prior to 
soaking in SBF solution does not play a role in the formation of cracks in the 
apatitic calcium phosphate layer. Rather, it indicates that the phases present on the 
alkali treated layer are more important parameters than sodium content for 
producing crack-free apatitic calcium phosphate coatings. 
It is important to emphasize that the SEM micrographs (Fig. 3.4) in this 
present study show significant differences in terms of crack formation on the 
apatitic calcium phosphate layer. Cracks were observed on the calcium phosphate 
layer deposited on the substrate containing 8.25 wt. % Na (Fig. 3.4a and 4b) 
whereas none were observed after soaking in SBF on the substrate previously 
containing 3.6 wt. % Na (Fig. 3.4c and 4d). The substrate surfaces both before 
and after water treatment, contains sodium titanate and rutile. No other phase (eg. 
anatase) was detected by the XRD. Since we rule out the possibility of the sodium 
contents affecting the crack formation, we can conclude that carbonate must play 
an important role in crack formation. The role of carbonates in forming cracks 
initially becomes visible just after the alkali treatment. The SEM micrograph in 
Figure 3.3a shows the NaOH-treated substrate without water treatment and also 
demonstrates a multitude of cracks on the sodium titanate surface. This is possibly 
due to the presence of (a) water, as these substrates are hydrated in nature, and (b) 
carbonates, as the FTIR pattern in Figure 3.2b confirms their presence. Significant 
differences are observed in the SEM micrographs after water treatment as no 
cracks are seen on the sodium titanate layer (Fig. 3.3b). The FTIR pattern in 
Figure 3.2c shows that the substrate is hydrated in nature and has no carbonate 
bands present. Thus, the presence of cracks in the alkali treated substrates 
occurring while drying is due to possible loss of carbonates as CO2 to the air. 
Since no carbonates were present in the water treated Ti6Al4V strips, no cracks 
were observed on the sodium titanate layer.  
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These substrates with/without cracks and with/without carbonates are 
soaked in SBF solution. During the final drying step, coatings with underlying 
carbonated titanate phase end up cracking because the carbonates are released 
from them. These cracks substantially increase the likelihood of delamination, 
thereby decreasing the implant’s bonding ability to natural bones. Thus, water 
soaking step is expected to improve the performance of coated Ti (or alloy) 
impants. 
 
3.5 Conclusions 
This paper presents results leading to the cause of crack formation in 
biomimetically coated Ti6Al4V strips. By performing carefully planned 
experiments, it was found that carbonates are present in the sodium titanate layer 
formed during the pre-treatment of the substrates. These carbonates during drying 
tend to evaporate from the underlying surface layer as CO2 and thus, results in the 
formation of deep cracks. Successful removal of carbonates from this surface 
layer was performed by incorporating a water soaking treatment prior to SBF 
soaking. Once the carbonates are removed, cracks cannot form during any 
subsequent drying step. This paper suggests a step in the protocol, which should 
be incorporated into the biomimetic coating process of titanium and related alloy 
substrates, to obtain crack-free coatings. 
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CHAPTER 4 
 
IN VITRO TESTING OF CALCIUM PHOSPHATE (HA, TCP, AND 
BIPHASIC HA-TCP) WHISKERS 
 
Abstract 
Calcium phosphate [single-phase hydroxyapatite (HA, Ca10(PO4)6(OH)2), single-
phase tricalcium phosphate (β-TCP, Ca3(PO4)2), and biphasic HA-TCP] whiskers 
were formed by starting with aqueous solutions containing NaNO3, HNO3, 
Ca(NO3)2⋅4H2O and KH2PO4 (with or without urea). These solutions were 
irradiated in a household microwave oven for 5 min. As-recovered precursors 
were then simply stirred in water at room temperature for 1 hour to obtain the 
whiskers of the desired calcium phosphate (CaP) bioceramics. Bioactivity and 
biocompatibility of these whiskers were evaluated, respectively, in vitro by (1) 
soaking those in synthetic body fluid (SBF) solutions at 37°C for one week, and 
(2) performing cell attachment and total protein assay tests on the as-formed 
whiskers by using a mouse osteoblast cell line (7F2). β-TCP, HA and HA-TCP 
biphasic whiskers were all found to possess a notable apatite-inducing ability 
when soaked in SBF. SBF-soaked whiskers of high nanoroughness formed a 
biomimetic CaP nanotexture. Although the osteoblast viability and protein 
concentrations were found to be the highest on the HA whiskers, cells were 
attached and proliferated on all the whiskers.  These bioactive whiskers are 
suitable to use as osteoconductive fillers in biopolymer-based hard tissue 
scaffolds especially in craniofacial and maxillofacial applications. 
 
 
 
 
 
(This work is published in J Biomed Mater Res A 78 (2006) 481–490)
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4.1. Introduction 
It is known that whiskers or fibers of many materials can be synthesized; 
however, the preparation of non-toxic and biocompatible whiskers still remains as 
an important task. Asbestos whiskers, for instance, which have been used for so 
many decades are now known to be biohazardous and extremely carcinogenic.1 
Toxicity and carcinogenic properties of SiC whiskers is well known.2-4 Therefore, 
it is important to explore other whiskers that are more biocompatible. Human 
body only uses the carbonated, alkali (Na+ and K+) and alkaline earth (Mg2+) ion-
doped, apatitic calcium phosphate as the sole inorganic, “ceramic” phase, when 
and where it needs to exploit the load-bearing ability of such strong materials. 
Therefore, whiskers of carbonated, apatitic calcium phosphates (CaP) are 
expected to be non-toxic and perfectly compatible with the human body.5-14 CaP 
whiskers were synthesized until now with the aim of using them as possible 
strengthening additives for the calcium phosphate (e.g., HA: Ca10(PO4)6(OH)2) 
bioceramics. Within this context, reinforcement by whiskers has been regarded as 
a means of raising the fracture toughness of single-phase HA from <1 to 2-12 
MPa⋅m1/2.15-17 We have recently reported18 a novel procedure which allowed to 
synthesize short whiskers of either single-phase HA, single-phase TCP or 
biphasic HA-TCP. 
Yoshimura and coworkers1,7,9,11 laid the foundation for the hydrothermal 
synthesis of hydroxyapatite whiskers and also for their use in reinforcing calcium 
phosphate bioceramics.19 These hydrothermal whisker synthesis procedures, 
which required aqueous solutions to be heated to 160–200°C in autoclaves, are 
not suitable (owing to the increased solubility and/or hydrolysis of β-TCP phase 
under such conditions) for the production of β-TCP or biphasic β-TCP-HA 
whiskers. 20 Molten salt synthesis techniques, on the other hand, are suitable for 
the synthesis of monodisperse β-TCP or biphasic whiskers.10 
To the best of our knowledge, none of the previously synthesized calcium 
phosphate whiskers has been in vitro tested by using the osteoblast cell lines. 
However, until now the osteoblast attachment and proliferation have been 
reported only on SiC whiskers, which were used to reinforce calcium phosphate 
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self-setting cements, bioceramics or polymers.21-24 The apatite-inducing ability of 
CaP whiskers,5-14, 18 when soaked in synthetic body fluid (SBF) solutions,25-27 was 
also not studied or reported yet.  
The present paper reports the in vitro testing of HA, TCP and biphasic 
HA-TCP whiskers18 by (1) soaking them in replenished SBF solutions for one 
week at 37°C, and (2) performing live/dead cytotoxicity counts, protein assay and 
cell attachment tests by using mouse osteoblasts (7F2). 
 
4.2  Experimental Procedure 
4.2.1 Sample Preparation. The details of calcium phosphate whisker 
preparation have been given elsewhere.18 Briefly, aqueous solutions containing 
dissolved NaNO3, Ca(NO3)2⋅4H2O, KH2PO4, concentrated HNO3, and urea (all 
reagent-grade, Fisher Chemicals, Fairlawn, NJ) were prepared in 10 mL of 
deionized water in 30 mL-capacity Pyrex beakers, as shown in Table 4.1. The 
first chemical added to the beakers was NaNO3, while the last one was urea. 
Small aliquots of concentrated HNO3 were added to dissolve back any colloidal 
precipitates that might have formed following the addition of Ca(NO3)2.4H2O and 
KH2PO4 into the NaNO3 solution. For each case shown in Table 4.1, clear-
transparent solutions were thus obtained. Sample beakers were then placed onto 
10 x 10 x 1 cm3 alumina insulating fiberboards and covered with an upside down 
250 mL-capacity glass beaker. To proceed with the synthesis process, the above-
mentioned sample assemblies were placed into a household microwave (MW) 
oven (Sunbeam, max. power 600 W, 2.45 GHz, Boca Raton, FL) for only 5 min. 
The MW oven was operated at its maximum power setting. At the end of 5 min of 
MW heating, the sample beakers reached a temperature of about 500 to 550°C 
and were slowly cooled to room temperature (RT), in the MW oven, during the 
next 20 min. 
The substance in the sample beaker was then placed into 500 mL of 
deionized water at RT [(22 ± 1)°C] and stirred with a Teflon-coated magnetic fish 
on a stirrer at around 300 rpm for 1 h, immediately followed by filtration (No. 42 
filter paper, Whatman Int., Maidstone, England) in a vacuum-assisted Buechner  
  
 
64
Table 4.1  Sample preparation for HA, TCP, and HA-TCP whiskers18 
Sample      NaNO3      Ca(NO3)2⋅4H2O   KH2PO4 15.69 M  Urea  Ca/P     
HNO3  
          (g)                   (g)       (g)     (mL)     (g) 
 
HA  5.00         1.00     0.345   0.10               1.75   1.67 
TCP  5.00         1.00     0.384   0.10                 1.50 
Biphasic 5.00         1.00     0.345   0.10            0.075   1.67 
 
funnel and washing with 2 L of water. The possible influence of varying the 
stirring rates on whisker synthesis was not studied. At the end of filtration the 
effluent solutions were transparent and free of whiskers. Samples were dried 
overnight at 80°C in air. 
4.2.2 Apatite-inducing ability test. Apatite-inducing ability of CaP whiskers 
were tested by soaking those in a synthetic body fluid (SBF) solution. The details 
of preparing these solutions were previously given elsewhere.26 Briefly, the SBF 
solution we used was a tris/HCl-buffered, 27.0 mM HCO3- ion-containing 
solution with the ion concentrations as given in Section 3.2.2 Table 3.1. 
The distinctive characteristic of SBF solutions utilized in this study was 
that they had the same carbonate ion concentration with that of human blood 
plasma. In vitro tests were performed in 100 mL-capacity glass bottles, which 
contained two grams of HA, TCP or biphasic HA-TCP whiskers and 90 mL of 
SBF solution. Sealed bottles were kept in an oven at 37±1°C for one week. 
However, after every 48 hours, the used SBF solution was replenished with a 
fresh one. Recovered samples (after 1 week) were washed with an ample supply 
of deionized water, followed by drying at 37°C for 48 hours in air. 
4.2.3 In vitro cell culture. 7F2 mouse osteoblast cells (CRL-12557, American 
Type Culture Collection, Rockville, MD) were grown on 75 cm2 culture flasks at 
37ºC and 5% CO2 in alpha-minimum essential medium (MEM) with 2 mM 1-
glutamine and 1mM sodium pyruvate, without ribonucleosides and 
deoxyribonucleosides, augmented by 10% fetal bovine serum (FBS). 28 The 
culture medium was changed every other day until the cells reached a confluence 
of 90-95%, as determined visually by using an inverted optical microscope. The 
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cells were then passaged using trypsin (2.5g/L) EDTA (25mM) solution (Sigma-
Aldrich). The obtained cells were then seeded at a concentration of 10,000 
cell/well on approximately 6 mm (diameter) x 6 mm (in height) cylindrical 
samples for various assays. A sintered Al2O3 disc was used as the control sample. 
Cell viability assessment was performed after 72 hours and total protein amount 
measurements were done after 7 days in a 96-well cell culture plate. The medium 
was replenished after the first day, and then on every 48 hours during the course 
of the experiments. After the prescribed time period for each test, substrates were 
rinsed with phosphate-buffered saline (PBS) solution to remove any non-adherent 
cells. For statistics, all experiments were performed in triplicate, where n=3. 
Analysis of variance was performed using the Tukey-Kramer multiple 
comparisons test. 
After 72 hours, live/dead cells were counted on the samples. The 
unattached cells were collected by trypsinization with 0.5 mL/well trypsin-EDTA 
solution and were incubated for 10 min. The cells were collected in a conical tube, 
1 mL of media was added and centrifuged for 5 min at 1000 rpm. The pellet 
formed at the base was resuspended in 1 mL media. Finally, trypan blue was 
added and the cells were counted under an optical microscope. Only cells that 
stain blue were deemed necrotic because of plasma membrane damage. 
The total protein assay was measured using BCA™ Protein Assay Kit 
(Pierce Biotechnology, Rockford, IL). A working reagent (WR) was prepared by 
mixing 50 parts of BCA™ Reagent A with 1 part of BCA™ Reagent B. A 200 µL 
aliquot of the above-mentioned WR was added to each well and thoroughly 
mixed. Following mixing, the cell culture plate was covered and incubated at 
37ºC for 30 min. The absorbance at 562 nm was measured with a 
spectrophotometer at room temperature. A standard curve was prepared by 
plotting the average blank-corrected 562 nm measurement for BSA standard 
versus its concentration in µg/mL. Protein concentration of each sample was then 
determined by using this standard curve. 
Osteoblast attachment and proliferation on the samples were examined by 
using FESEM. Prior to FESEM investigations, cells were fixed by using 3.5% 
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glutaraldehyde. The cells were dehydrated with increasing concentrations of 
ethanol (50%, 75%, 90% and 100%) for 10 minutes each. Critical drying was 
performed according to the previously published procedures. 20 Samples were 
sputter-coated with Pt prior to the FESEM imaging at 5 kV. 
All cell culture experiments were performed in triplicate and the data were 
expressed as the mean of three experiments. Statistical analyses were performed 
using SPSS 8.0 software (Chicago, IL). Fisher’s Least Significant Difference 
(LSD) test was used at a confidence level of 95%, therefore, p values _0.05 were 
considered significant. 
4.2.4 Characterization. Samples were characterized by powder x-ray diffraction 
(XRD) (XDS 2000, Scintag, Sunnyvale, CA), Fourier-transform infrared 
spectroscopy (FTIR) (Nicolet 550, Thermo-Nicolet, Woburn, MA), field-emission 
scanning electron microscopy (FESEM) (S-4700, Hitachi, Tokyo, Japan), and 
inductively-coupled plasma atomic emission spectroscopy (ICP-AES) (61E, 
Thermo-Jarrell Ash, Woburn, MA) analysis. 
 
4.3 Results and Discussion 
Figures 4.1a and b display the SEM morphology of the starting β-TCP 
(whitlockite) whiskers used in this study. The morphology of HA and biphasic 
HA-TCP whiskers were the same as reported previously.18 The biphasic whiskers 
initially contained 60% TCP and 40% HA, prior to the SBF-soaking. Inductively-
coupled plasma analyses of the starting whiskers of HA, TCP and biphasic HA-
TCP revealed that they contain around 1.5 wt% Na and 250 ppm K. With such a 
presence of alkali ions, it becomes impossible to name these whiskers as fully 
stoichiometric HA or TCP. The mineralized portion of human bones is not 
consisting of pure Ca10(PO4)6(OH)2, it contains elements like Na+, K+, and Mg2+ 
up to the significant level of 1.3 wt%.15 Bone mineral is also rich in carbonate 
ions, i.e., 5.8 wt% of its total weight.15 
 The SEM photomicrographs of Figure 4.2 depicted the unique 
morphology of TCP, HA-TCP, and HA whiskers after being soaked in the SBF 
solution at 37°C for one week. All of the SBF-soaked whiskers comprised 
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(a) 
 
 
(b) 
Fig. 4.1 FESEM photomicrographs of β-TCP whiskers 
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surfaces covered with carbonated apatitic calcium phosphates with a nanoscale 
roughness. To the best of our knowledge, CaP whiskers (of initial composition of 
either TCP, biphasic HA-TCP, or HA) with such a morphology have never been 
synthesized and reported. We hereby propose to name this morphology as the 
“biomimetic (SBF-grown) CaP nanotexture.” The same surface texture appears 
whenever and wherever one uses an SBF solution to grow calcium phosphates 
regardless of the substrate used. Biomimetic CaPs grown in an SBF solution on 
Ti6Al4V strips or the CaP precipitates formed in SBF solutions always had the 
same nanotexture.30 
The morphology of TCP whiskers (Fig. 4.2b) soaked in SBF was 
significantly different than that of HA whiskers (Fig. 4.2f), which has underwent 
exactly the same treatment. TCP samples exhibited a finer, more intimately 
interwoven surface, whereas in the case of HA the texture was much coarser. The 
BET surface areas of all samples are reported in Table 4.2. The highest 
experimental surface area value measured for the SBFsoaked TCP whiskers 
corresponded very well with the highest nano-roughness / nano-texture visually 
observed for these samples (compare Fig. 4.2b with Figs. 2d and 2f). 
Powder X-ray diffraction and FT-IR data for the SBF-soaked whiskers are 
given in Figures 4.3 and 4.4, respectively. Prior to collecting these XRD and FT-
IR data, the SBF-soaked whiskers (2 g in each SBF-soaking bottle) were ground 
into a fine powder by using an agate mortar and a pestle. The XRD and FT-IR 
data presented in Figures 4.3 and 4.4, therefore, were not limited only to the 
surfaces of the whiskers. According to XRD data, TCP whiskers almost 
completely transformed into apatitic calcium phosphates after one week of 
soaking in the synthetic body fluid (Fig. 4.3). Since SBF solutions can only form 
apatitic CaP (but not TCP), neat HA whiskers soaked in SBF solutions again 
yielded characteristic HA patterns (Fig. 4.3). On the other hand, XRD peaks for 
crystalline β-TCP were still visible in the SBF-soaked biphasic HA-TCP samples. 
FT-IR data of Figure 4.4 revealed the presence of CO32- (1480-1420 and 
873 cm-1) and HPO42- groups (870, 1133 and 1210 cm-1) in all the SBF-soaked 
samples.31 Most of the time it may become somewhat difficult to distinguish 
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Table 4.2 BET Surface Areas of Sample 
 
 
    
    
   
 
Fig. 4.2 FESEM photomicrographs of SBF-soaked whiskers, (a) & (b): β-TCP 
whiskers; (c)  & (d): biphasic HA-TCP whiskers; (e) & (f): HA whiskers 
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Fig. 4.3 XRD traces of SBF-soaked whiskers (* denotes TCP peaks) 
 
 
Fig. 4.4 FTIR traces of SBF-soaked whiskers 
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between the resembling FT-IR spectra of β-TCP and HA, and for this purpose the 
FT-IR trace of single phase β-TCP (99%, Fluka) powders is presented here in 
Figure 4.5. For β-TCP, there were no absorption bands present over the range 
4000 and 1300 cm-1. It is visible from Figure 4.5 that there are at least 25 
absorption bands in the characteristic FT-IR trace of pure β-TCP samples 
Relying on the experimental solubility values of some of the calcium phosphate 
phases reported by Tang et al. 32, it is seen that the dissolution rate of β-TCP (i.e., 
1.26x10-4 mol/m-2 min-1) in an aqueous solution at a pH of about 6 is about 89 
times greater than that of carbonated apatite, 1.42x10-6 mol/m-2 min-1. According 
to this, it is not difficult to assume that the whiskers of TCP of this study would 
dissolve in the SBF solution (in 1 week, at 37°C) at a much faster rate than those 
of HA. The dissolution of TCP in aqueous solutions can be described by the 
following reaction: 
 
3Ca3(PO4)2 (s) + H2O → 9Ca2+(aq) + HPO42-(aq) + 5PO43-(aq) + OH-(aq) (1). 
 
During the dissolution of β-TCP, the above aqueous ions combine to form 
what is known as calcium-deficient hydroxyapatite (CDHA), 
Ca9(OH)(HPO4)(PO4)5.33 CDHA can also incorporate CO32- ions, and it lacks one 
Ca2+ and one OH- in the unit cell of its crystal structure. CDHA yields the same 
XRD pattern with that of stoichiometric hydroxyapatite, HA.  
The bottom XRD trace shown in Figure 4.3, thus, belonged to the newly 
formed CDHA on and along the initial TCP whiskers, until their total 
consumption during the process, and this pattern was extremely difficult to 
differentiate from that of HA. The original TCP whiskers, in a sense, behaved like 
a “guiding scaffold” for the formation or regeneration of biomimetic CaP with a 
unique rod-like morphology. The detection of HPO42- bands in the FTIR data of 
Figure 4.4 also confirmed the formation of carbonated CDHA after soaking the 
whiskers in SBF.34 Such non-stoichiometric, carbonated apatitic calcium 
phosphates can readily accommodate a Ca/P molar ratio between 1.67 and 1.33 
(i.e., octacalcium phosphate, OCP, Ca8H2(PO4)6⋅5H2O). OCP is an acidic calcium  
  
 
72
 
 
 
 
 
 
 
 
 
 
Fig. 4.5 FTIR trace of pure β-TCP powders 
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phosphate salt, and the formation of it in neutral aqueous solutions of pH 7.4 
(such as SBF) is extremely difficult, if not impossible. The strongest XRD 
reflection for the OCP phase is to be detected at d-spacing = 18.703 Å, however, 
the XRD data of the SBF-soaked whiskers of this study did not exhibit this peak. 
SBF solutions are supersaturated with respect to apatitic calcium 
phosphate nucleation due to their high Ca/P molar ratio of 2.5, and therefore, even 
when they are optically transparent, they contain calcium phosphate clusters with 
sizes around 10 Å. 35 These CaP clusters were first described by Betts and Posner 
et al.36 to have the Ca9(PO4)6 stoichiometry, and are now known as Posner 
clusters. These clusters present in the SBF solutions aggregate to produce the 
biomimetic CaP nanotexture, while filling the intercluster spaces with water and 
bicarbonate molecules. Dorozhkina and Dorozhkin37 quantitatively confirmed the 
carbonated nature of such clusters when they reached the micron-size range. 
Dissolution of β-TCP provided the SBF solution, at the dissolution 
interface, with the aqueous ions given in equation (1), and the presence of these 
ions triggered the hexagonal packing of Posner clusters35 of the SBF to form 
carbonated, nano-textured, apatitic calcium phosphates on the whiskers [Figs. 
4.2a and b). When HA was present as a phase in those whiskers (since it had a 
significantly lower solubility in comparison to β-TCP), the supply of those ions to 
the solution was slowed down. This was why the XRD traces (Fig. 4.3) of 
biphasic HA-TCP still contained peaks of β-TCP. In the case of pure HA 
whiskers (Figs. 4.2e and f), the formation of the biomimetic CaP nanotexture was 
much more incomplete as compared to those of β-TCP whiskers (Figs. 4.2a and 
b), due to their almost two order of magnitude lower solubility. As expected, 
biphasic HA-TCP whiskers had taken an intermediate place in between the pure 
TCP and pure HA samples, in terms of forming that interlocking, intermingling 
biomimetic CaP nanotexture. 
The characteristic surface morphology of the neatwhisker cylinders (6 mm 
x 6 mm) on which the osteoblast cells were cultured is given in the SEM 
micrograph of Figure 4.6. As a result of the pressing action, whiskers formed a 
porous compact while maintaining their individual shapes.  Mouse osteoblast cells 
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(7F2) cultured on whisker samples (as is, not soaked in SBF) exhibited 
differences in terms of the number of attached cells and protein concentration, as 
presented in Figures 4.7a & b. The number of attached cells and the measured 
protein concentrations were found to yield the highest values for HA whiskers.  
The results of the Fisher’s least significant difference (LSD) test are 
shown in Table 4.3. LSD test is basically a student’s t test using a pooled error 
variance, and is suitable for making pair-wise comparisons among a set of t 
population means. In Table 4.3, p values less than 0.05 indicated that there was a 
statistically meaningful and reliable difference. In other words, the cell attachment 
and protein concentrations registered for the Al2O3 control samples were 
statistically different than those of all the CaPs of this study.  
At the significance level of 0.05, when TCP was compared with HA in 
terms of cell attachment and total protein concentration, the p values for both LSD 
tests came out to be less than 0.05 (as shown in Table 4.3). Therefore, we are 95% 
confident that there is a difference in cell viability and total protein concentration 
between HA and TCP whisker compacts. However, it was not possible to detect 
any statistical difference between HA-TCP and TCP or HA-TCP and HA in terms 
of number of cells attached and protein concentration. 
Osteoblast attachment and proliferation on the surfaces of whisker 
samples was monitored by SEM, and given in Figures 4.8a through f. Osteoblasts 
were attached to the surfaces of all the whisker samples tested here, however, the 
high-magnification pictures showed significant differences in osteoblast 
proliferation.  
Osteoblast behavior is sensitive to the biochemical and topographical features 
(i.e., chemical and physical microarchitecture) of their substrate. The ideal and 
most preferred surface used by osteoblasts in vivo is the osteoclast resorption 
pits.38 The cell attachment and the protein assay histograms given in Figures 4.7a 
and 4.7b clearly showed that the CaP whiskers always performed better than the 
control samples of sintered, dense Al2O3. Mouse osteoblasts were able to easily 
differentiate between the chemical compositions of the CaP whiskers. In other 
words, osteoblasts favored whiskers of hydroxyapatite (HA) those of over β-TCP  
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Fig. 4.6  FESEM micrograph of the surface of whisker cylinders used in cell 
culture tests. 
 
 
 
 
Table 4.3    p Values for the Number of Cells Attached and Protein Concentration 
 
Test  Control HA HA-TCP    TCP 
Control - 0.001* 0.006*   0.019* 
HA 0.001* - 0.143   0.041* 
HA-TCP 0.006*   0.143  - 0.441 
No. of 
Cells 
Attached TCP 0.019* 0.041* 0.441 - 
Control - 0 0* 0* 
HA 0* - 0.159    0.019* 
HA-TCP 0*   0.159 -   0.202 
Total 
Protein 
Conc. 
TCP 0* 0.019* 0.202 - 
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(a)  
 
(b)  
Fig. 4.7 (a) Number of attached cells on whiskers (control: Al2O3) and (b) 
Protein assays for whiskers (control: Al2O3) 
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Fig. 4.8 FESEM photomicrographs of osteoblast proliferation on whiskers, (a) & 
(b): β-TCP whiskers; (c) & (d): biphasic HA-TCP whiskers; (e) & (f): 
HA whiskers 
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or biphasic HA-TCP. It is a well-known fact that the surface chemistry of a 
material determines the initial in vitro interactions of proteins, such as fibronectin 
with integrin cell-binding domains, which in turn regulate the cell adhesion 
process. Osteoblast response to the CaP surfaces of this study can be regarded as 
the sum of their ability to attach, proliferate, and differentiate. In the attachment 
stage, osteoblast filopodia explore the substrate topography for areas to which a 
greater surface area of the cell can adhere. These filopodia are used in sensing the 
substrate, and they extend over significant distances to find areas appropriate for 
attachment.39 All of the FESEM micrographs of Figure 4.8 revealed the readily 
extension of those filopodia. 
On whisker surfaces, cells were flattened and spread with clear actin fibers 
associated with vinculin adhesion plaques (Fig. 4.8). For instance, the FESEM 
micrograph of Figures 4.8a and b, recorded on the surfaces of β-TCP whiskers, 
clearly showed the actin cytoskeleton and the stress fibers. On the other hand, the 
micrographs of Fig. 4.8d and f displayed the vinculin adhesion plaque formation 
on the biphasic HA-TCP and HA whiskers, respectively.  
Cells are known to produce fewer adhesion plaques while still in the 
process of migration than once permanently settled in place.40 Sun et al.41 exposed 
cells to calcium phosphate particles and reported that HA particles (100 nm) or β-
TCP particles (100 nm) inhibited the growth of primary mouse osteoblasts, while 
causing an increase in their expression of alkaline phosphatase.42 In addition, 
Pioletti et al.43 observed a decrease in growth, viability, and synthesis of 
extracellular matrix (ECM) in primary mouse osteoblasts that were exposed to β-
TCP particles (1–10 µm) or CaHPO4⋅2H2O particles (1–10 µm). A 90% decrease 
in viability was reported by Pioletti et al.43 when evaluated using a Live-Dead 
assay similar to what we have used in this study. Our results with the β-TCP 
whiskers also confirmed the findings of Pioletti et al.43 The bone depositing cells, 
i.e., osteoblasts, always prefer more basic surfaces to attach and proliferate, and 
this was also confirmed in the present study. The basicity of the whiskers 
increased in going from β-TCP (neutral pH) to HA (pH> 9). The pH values of as-
synthesized whiskers were measured, at 37°C, by inserting a pH electrode into 
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suspensions prepared by adding 1 g of whiskers into 5 mL deionized water, and 
after keeping the whiskers in these for 15 min. 
CaP particles and other bioactive materials have been used as fillers in 
polymer-based bone cements to improve their mechanical properties.44-47 Besides 
calcium phosphates, SiC whiskers were also used as fillers, for instance, to 
reinforce Bis-GMA-based dental resins to extend their use to large load-bearing 
restorations.20 The SiC whiskers possessed a high structural perfection resulting in 
superior strength values. While plain whiskers did not significantly strengthen the 
resin matrix, nano-silica attachment (on the whiskers) was reported48 to roughen 
the whisker surfaces and enhanced whisker retention in the matrix, resulting in 
strong composites with substantially increased strength and toughness. 
Nevertheless, even calcium carbide “ceramic” particles are not resorbable in vivo, 
and their cytotoxicity behavior, in case they go into the bloodstream of a patient 
and possibly end up in kidneys and/or liver are not known at all.49 
The SBF-soaked β-TCP, biphasic HA-TCP, and HA whiskers reported in 
this study have a very high nanoscale surface roughness, and they are fully 
biocompatible with the human body. These novel whisker scaffolds will speak to 
the hypotheses recently developed by Webster et al.28,29 on the extraordinary 
bioactivity behavior observed on the surfaces of otherwise bioinert materials, such 
as Al2O3, ZrO2, or metallic alloys, when they possess some degree of nanoscale 
roughness. Our research on the incorporation of these SBF-soaked whiskers 
having a “biomimetic CaP nanotexture” into biopolymers, such as cross-linked 
gelatin or alginates, is in progress, which we plan to report in due time. These 
biopolymer-CaP composites will be utilized in craniofacial and maxillofacial 
surgery. 
 
4.4. Conclusions 
1. Whiskers of bioactive β-TCP, biphasic HA-TCP and HA have been 
synthesized by using a simple microwave-assisted molten salt synthesis 
procedure.18 This procedure readily allowed for the on demand synthesis of 
any of these whiskers. 
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2. When soaked in synthetic body fluid (SBF) solutions for 1 week at 37°C, all 
of the whiskers were found to form carbonated, apatitic calcium phosphates, 
while still retaining their whisker form. 
3. After SBF-soaking a unique “biomimetic CaP nanotexture” was observed on 
the surfaces, which imparted to the whiskers a nanoscale surface roughness. 
4. In vitro cell culture tests performed with the mouse osteoblasts (7F2) on the 
whiskers showed increasing cell attachment and protein concentration rates 
in the following order: HA > biphasic HA-TCP > β-TCP. 
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CHAPTER 5 
 
A NEW RHENANITE (β-NaCaPO4) AND HYDROXYAPATITE BIPHASIC 
BIOMATERIAL FOR SKELETAL REPAIR 
 
Abstract 
Biphasic β-rhenanite (β-NaCaPO4)–hydroxyapatite (Ca10(PO4)6(OH)2) 
biomaterials were prepared by using a one-pot, solution-based synthesis 
procedure at the physiological pH of 7.4, followed by low-temperature (300–
600°C) calcination in air for 6 h. Calcination was for the sole purpose of 
crystallization. An aqueous solution of Ca(NO3)2.4H2O was rapidly added to a 
solution of Na2HPO4 and NaHCO3, followed by immediate removal of gel-like, 
poorly-crystallized precursor precipitates from the mother liquors of pH 7.4. 
Freeze-dried precursors were found to be nanosize with an average particle size of 
45 nm and a surface area of 128m2/g. Upon calcination in air, precursor powders 
crystallized into biphasic (60% HA–40% rhenanite) biomaterials, while retaining 
their submicron particle sizes and high surface areas. β-rhenanite is a high 
solubility sodium calcium phosphate phase. Samples were characterized by XRD, 
FTIR, SEM, TEM, ICP-AES, TG, DTA, DSC, and surface area measurements.  
 
 
 
 
 
 
 
 
 
 
(This work is published in J Biomed Mater Res Part B 80 (2007) 304–316)
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5.1. Introduction 
In orthopedic, oral and maxillofacial surgery, a variety of synthetic bone 
grafts have been used to fill skeletal defects originating from tumor resection, 
trauma, or infection.1–3 Synthetic calcium phosphates, such as calcium 
hydroxyapatite [HA; Ca10(PO4)6(OH)2], β-tricalcium phosphate [β-TCP; β -
Ca3(PO4)2] and biphasic mixtures of these two have found use as bone 
substitutes.4–6 HA or β-TCP implants exhibit relatively good tissue compatibility, 
and new bone is formed directly on the implants with no fibrous encapsulation.7 
However, sintered and well-crystallized HA ceramics usually demonstrated 
minimal in vivo resorption, with resorption times lagging the new bone formation 
rates.8–12 Kilian et al. 13 showed that nonsintered HA could even be phagocytized 
and dissolved by macrophages and osteoclasts, while sintered ceramics were not 
degraded and remained at the site of implantation for years following the surgery. 
β-TCP, on the other hand, has a significantly high solubility14,15 and typically 
fades away from the defect site even before the  completion of new bone 
formation. An ideal skeletal repair implant should readily take part in the bone 
remodeling processes, and also allow for the direct anchorage by the bony tissues 
surrounding it (osteoconduction).16 If the skeletal repair implant itself causes the 
in situ formation of the mineral part of the bone tissues (osteoinduction) rich in 
carbonated, apatitic calcium phosphates,17 while it is continuously resorbing (in 
vivo osseointegration), this could be its most affirmative contribution to the defect 
site.18–21 Therefore, efforts in the direction of developing calcium phosphate-
based bone substitutes of higher in vivo resorbability and 
osteoinductive/osteoconductive capabilities are still needed.  
In stark contrast to sintered HA ceramics,10,11 calcium phosphate (CaP) 
self-setting cement formulations, which intentionally employed poorly-
crystallized apatite as their major powder component, were shown22–24 to have 
significant in vivo resorbability (i.e., with resorption rates in excess of 98% in 26 
weeks following the implantation in the case of, for instance, α-BSM™, Etex, 
Cambridge, MA). These cements rapidly took part in the bone remodeling 
processes by going through phagocytosis under the action of macrophages and 
  
 
87
osteoclasts.22 Besides these special orthopedic cements, such high resorption rates 
with calcium phosphates have only been encountered when the tested (in vivo) 
materials comprised nanoapatites.25  
Bone is a connective tissue with extracellular substance consisting of a 
carbonated, apatitic calcium phosphate nanosize mineral dispersed in what is 
essentially a hydrated collagen matrix. The mineral portion comprises two 
intimately mixed calcium phosphate phases; (i) noncrystalline or amorphous 
calcium phosphate and (ii) a poorly-crystallized apatitic calcium phosphate. In the 
formation of bone mineral, the amorphous phase is laid down first by the bone-
depositing cells, i.e., osteoblasts, and subsequently a significant portion of this is 
then converted in the physiological environment to the carbonated, Na-, K-, and 
Mg-doped, Ca-deficient bioapatite during the in vivo maturation of bones.26 The 
presence of the noncrystalline calcium phosphate phase in bones has been 
detected even by the very first electron microscope studies.27 The earlier work of 
Posner and coworkers28–35 set the foundation for the synthesis and 
characterization of amorphous or poorly-crystallized calcium phosphate powders. 
The cytoplasmic calcium phosphate mineral was found to have a structure built up 
of close-packed ion clusters of about 10 Å similar to those of Ca9(PO4)6 present in 
synthetic amorphous calcium phosphates. Short-range order existed in these 
amorphous clusters (i.e., Posner clusters) but no long-range order was detected as 
crystalline hydroxyapatites have.35 The work of Eanes and coworkers36–43 and 
Rey and coworkers24,44–52 on the preparation of poorly-crystallized calcium 
phosphates should also be cited in this context.  
β-Rhenanite (β-NaCaPO4) is an alkali calcium orthophosphate, which was 
recently shown to support cellular proliferation together with expression of 
osteogenic markers at a level higher than β-TCP,53 and NaCaPO4 was, therefore, 
suggested to possess a higher potency to enhance osteogenesis than β-TCP. 
Ramselaar and coworkers54–57 were the first to investigate the biodegradation rate 
of NaCaPO4 implants in direct comparison to HA and β-TCP from six weeks to 
three months in vivo. Knabe et al.58 noted the remarkably high solubility (1.0 g 
per liter of H2O at pH 7.54) of NaCaPO4 samples in a comparative set of in vitro 
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rat bone marrow cell culture tests performed on a number of calcium phosphates. 
Suchanek et al.59 discovered the formation of NaCaPO4 interphase layers of high 
biocompatibility during the hot pressing of hydroxyapatite and bioactive glass 
powders together. Glass ceramics which contained NaCaPO4 as the crystalline 
phase were also reported to be bioactive.60–62  
On the other hand, “Rhenania process” is a well-known procedure mostly 
used in the fertilizer industry to obtain a soluble phosphate material.63 In this 
process, the natural mineral of hydroxyapatite is mixed with Na2CO3 and SiO2 
whereas the molar ratio of Na2CO3/P2O5 fixed at 1.0. SiO2 is added to prevent the 
occurrence of free CaO in the sintered product. These powder mixtures are then 
ground together and calcined in a rotary kiln at about 1000–1200°C for about few 
hours. Rhenanite, NaCaPO4, of high solubility, has been the major phase in the 
final product of the Rhenania process.63 As could be expected, NaCaPO4 received 
such a high-temperature treatment has a rather low surface area, low surface 
reactivity, and larger powder particles. 
Resorbable, granular bone graft substitutes based on NaCaPO4 
formulations have already been commercialized and marketed for the orthopedic 
surgeons.64,65 Self-setting cements based on NaCaPO4 are also available for the 
repair of bone defects.66 Nevertheless, the powders of such products have been 
produced by high-temperature (>1100°C) processes.64  
The motivation for the present study stems from our interest in developing 
a robust synthesis route for the manufacture of biphasic nanopowders of 
NaCaPO4 and carbonated, apatitic calcium phosphate using temperatures less than 
700°C. Specifically, the apatitic calcium phosphate powders are known to lose 
their carbonate ions when and if a temperature higher than 700°C was used.67 The 
soluble component of these biphasic mixtures (i.e., NaCaPO4), under the in vivo 
action of osteoclasts, is assumed to supply Ca2+ ions, as well as hydrogenated 
phosphate ions, to the surrounding tissues upon implantation. Such materials can, 
therefore, be expected to act like an osteoinductive stimulant in the body.  
Therefore, our experimental approach to that end was framed around the 
following straightforward supposition: “amorphous or poorly-crystallized calcium 
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phosphate powders are known to consist of nanoparticles of apatitic calcium 
phosphates,24 and if those powders were synthesized at the physiological pH in 
the presence of a rather significant amount of Na+ ions, then upon calcining those 
powders over the temperature range of 300–600°C, the resultant material should 
be a biphasic powder mixture of NaCaPO4 and apatitic calcium phosphate with a 
high surface area.” This work, to the best of the knowledge of authors, reports for 
the first time the aqueous preparation of nanosize calcium phosphate precursor 
powders, which are able to readily transform into biphasic powder mixtures of β-
NaCaPO4 and carbonated hydroxyapatite upon low-temperature calcination.  
 
5.2. Experimental Procedure 
5.2.1 Synthesis of Calcium Phosphate Powder Samples. The synthesis method 
used to form the Na-containing poorly-crystallized apatitic calcium phosphate 
powders simply consisted of preparing two solutions, and the procedure adapted 
here was inspired by the work of Lee et al.68 Solution-A was prepared as follows; 
86.4 g Na2HPO4 (disodium hydrogen phosphate, >99%, Fisher Scientific, 
Fairlawn, NJ) was dissolved in 1.2 L of deionized water, followed by the addition 
of 60.0 g NaHCO3 (sodium hydrogen carbonate or sodium bicarbonate, >99%, 
Fisher), which resulted in a clear solution with a pH of about 9 at RT (22 ± 1°C). 
Solution-B was prepared by dissolving 70.0 g of Ca(NO3)2.4H2O (calcium nitrate 
tetrahydrate, >99%, Fisher) in 500 mL of deionized water. Solution-B was then 
rapidly added into solution-A under constant stirring (at 250 rpm, with a 5 cm 
long, Tefloncoated magnetic fish) at room temperature. The pH of the resultant 
milky suspension (with a nominal Ca/P molar ratio of 0.49) was then rapidly 
raised to around 7.4, i.e., the physiological pH value, by adding 3 – 5 mL   of 
concentrated NaOH solution. The solids were immediately filtered by using a 
filter paper (No. 42, Whatman International, Maidstone, UK) placed in a vacuum-
suction porcelain Buechner funnel assembly, and washed with 4 L of deionized 
water. Upon filtering and washing the   precipitates in the funnel one obtains a 
gel-like calcium phosphate precipitate body (i.e., CaP gel). Some portion of the 
recovered gels was placed in a glass Petri dish and dried at 37°C for 72 h in static 
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air in a drying oven, while the remainder of the sample was first frozen at -80°C 
for 2 h, and then lyophilized in a vacuum chamber (Freezone® 4.5, Labconco, 
Kansas City, MO) kept at 5 x 10-2 mbar at RT overnight. The above-mentioned 
synthesis recipe has been repeated six times, and the reproducibility in the 
composition of precursor powders was checked by consecutive triplicate chemical 
analyses.  
To test the influence of solution pH on the phase composition of the 
resultant precipitates, in a number of experiments the pH of Solution-A was first 
decreased to 4.2 at room temperature, under vigorous stirring, by slowly adding 
aliquots of concentrated HNO3 (69.2%, Fisher Scientific, Fair Lawn, NJ). The pH 
value of Solution-B was also reduced to 4.2 by adding HNO3, followed by adding 
Solution-B into Solution-A rapidly, as described above. The precipitates were 
then immediately filtered out of the mother liquor in a fashion similar to that 
mentioned above.  
CaP powders obtained at pH 7.4 placed in clean aluminum oxide crucibles 
or boats were calcined in a static air atmosphere in an electrically-heated muffle 
furnace (5°C/min heating and cooling rates) over the temperature range of 300–
600°C, with 6 h of soak time at the peak temperatures. Calcined samples were 
lightly ground (only for few minutes) in an agate mortar by using an agate pestle. 
To test the sinterability of these rhenanite–HA biphasic samples, we have 
uniaxially pressed (5000 kg/cm2) eight pellets (each 1.5 mm thick) out of the 
600°C-calcined biphasic powders. These pellets were then separately heated in an 
electrical resistance, chamber furnace to 1000°C at the rate of 5°C/min, held at 
that temperature for 6 h, and then cooled back to room temperature within the 
furnace either at the rate of 5°C/min or 1°C/min.  
5.2.2 Powder Characterization. Samples were characterized, at all stages, by 
powder X-ray diffraction (XRD Model XDS 2000, Scintag, Sunnyvale, CA), 
scanning electron microscopy (SEM, Model S-4700, Hitachi, Tokyo, Japan), 
transmission electron microscopy (TEM, Model HD200, Hitachi), Fourier-
transform infrared spectroscopy (FTIR, Model Nicolet 550, Thermo-Nicolet, 
Woburn, MA), inductively-coupled plasma atomic emission spectroscopy (ICP-
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AES, Model 61E, Thermo Jarrell Ash, Woburn, MA), thermogravimetry 
(TG/DTA, Model 851e, Mettler-Toledo, Columbus, OH) and differential scanning 
calorimetry (DSC, Model SDT 2960, TA Instruments, New Castle, DE) analyses, 
and surface area measurements (Model ASAP 2020, Micromeritics, Norcross, 
GA).  
Powder samples for XRD analyses were first ground in an agate mortar 
using an agate pestle and then sprinkled onto ethanol-damped single crystal quartz 
sample holders as a thin and flat layer, followed by tapping to remove the excess 
of powder. The X-ray diffractometer was operated at 40 kV and 30 mA with 
monochromated Cu Kα radiation. XRD data were collected in the step mode over 
the 2θ range of 3°–50°, with a scanning speed corresponding to 0.01° per minute. 
FTIR samples were first ground in a mortar, in a manner similar to that used in 
the preparation of XRD samples, and then placed onto the diamond ATR holder 
of the FTIR spectrometer. This spectrometer was equipped with an Endurance 
Foundation Series single-bounce diamond ATR (50° incidence angle), and 32 
scans were performed at a resolution of 4 cm-1. Powder samples examined with 
the scanning electron microscope (SEM) were sputter-coated with a thin Pt layer, 
just prior to imaging, to improve the conductivity of samples. For the transmission 
electron microscope (TEM) investigations, small aliquots of respective powder 
samples were first dispersed in pure ethanol, and then few drops of those 
suspensions were dried on the sample holder grids. The BET surface area of 
powder samples was determined by applying the standard Brunnauer–Emmet–
Teller method to the nitrogen adsorption isotherm obtained at -196°C using the 
Micromeritics ASAP 2020 instrument. Powder samples used in the ICP-AES 
analyses were first dissolved in nitric acid prior to measurements. For carbon 
analyses, 200 mg of powder samples was combusted at around 1200°C in oxygen 
atmosphere by using a C analyzer (Model Vario Macro, Elementar, Mt. Laurel, 
NJ). In this process, carbonaceous moieties were converted into CO2, and after 
catalytic post-oxidation, drying, and cleaning of carrier gas, all carbon oxides are 
reduced to molecular carbon over a reducing agent and transported by the carrier 
gas to the thermoconductivity cell for the final quantitative determination of 
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carbon content. Carbon content was then reported by the computer of the 
instrument as wt % C present in the samples. We converted the measured C 
contents into CO3 percentages. Thermogravimetric analyses (TGA) of the CaP gel 
(or powder) samples were performed in Pt crucibles in a static air atmosphere 
with a heating rate of 5°C/min from RT to 800°C. Water content of the precursor 
powders were directly deduced from the TGA traces. DTA and DSC runs were 
also performed in Pt crucibles in flowing air atmosphere with a heating rate of 
5°C/min, and Al2O3 powder was used as the reference sample in these 
experiments.  
 
5.3 Results and Discussion 
The synthesis procedure described in Synthesis of Calcium Phosphate 
Powder Samples was able to produce apatitic calcium phosphate powders when 
the synthesis solution pH was maintained at 7.4. The results and data given below 
are all for pH 7.4 samples, unless otherwise noted. XRD data for 37°C- and 
freeze-dried CaP gels were given in the comparative chart of Figure 5.1a. Both 
traces were characteristic of poorly-crystallized CaP powders,24,46–52 although 
drying at 37°C seemed to cause a slight increase in the overall crystallinity with 
respect to freeze drying. In freeze drying, the water initially present was gradually 
sublimed, whereas in 37°C drying that water present at the end of the washing 
step helped the crystallization to proceed at a low rate. Freeze-dried powders were 
found to be fluffier with respect to those dried at 37°C, therefore, after the 
preliminary experiments all of the powders obtained by aqueous synthesis 
procedure were freeze-dried. Surface area measurements also confirmed this 
observation, and the BET surface area of freeze-dried powders was 128 ± 5, 
whereas that of the powders dried at 37°C for 72 h was 62 ± 3 m2/g. 
Adult human bones yield XRD data very similar to those given in Figure 
5.1a.69,70 If the syntheses were to be carried out under refrigeration, e.g., at around 
4°C, the XRD charts obtained would consist of, more or less, X-ray amorphous 
traces.68 The hydrated nature of CaP gel samples dried at 37°C were also 
confirmed by the wide water bands displayed in their FTIR spectra given in 
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Figure 5.1b. On the other hand, in the FTIR spectra of freeze-dried samples, the 
intensities of those water bands have been significantly reduced (Fig. 5.1b). 
Therefore, drying at 37°C did not completely eliminate the water present in those 
precipitated precursor gels. The symmetric and antisymmetric stretching of the 
PO4-3 group were observed at 1097, 1043, 964, 604, and 565 cm-1. Bands of CO32- 
ions were observed at 1470–1420 and 875 cm-1. The very weak IR band at around 
919 cm-1 and again the weak shoulder at around 1297–1310 cm-1 were attributed 
to the smaller presence of HPO42- ions.71 HPO42- ions do also have a band at 874 
cm-1, which partially overlaps with that of CO32- ions rendering the distinction 
between HPO42- and CO32- ions more difficult. In contrast to our findings, Wu et 
al.45 previously noted that unique HPO42- group present in the human bone 
mineral was not seen in synthetic CaP samples produced under conditions similar 
to those of this study. The synthesis procedure adopted and used in this study was, 
therefore, able to produce a hydrated and carbonated CaP gel precursors, which 
contained a trace amount of protonated orthophosphate ions similar to the human 
fetal bones (Fig. 5.1b). The ICP-AES and C analyses results are given in Table 
5.1. Analyses were performed in triplicate on all the samples. Freeze-dried CaP 
gel precursors gave the following medians: Ca: 21.27 ± 0.02%; P: 13.27 ± 0.01% 
and Na: 9.10 ± 0.01 wt %, which corresponded to a molar Ca/P ratio of 1.239 
(Table 5.1), and a molar (Na+Ca)/P ratio of 2.163 in these powders. It is not so 
surprising that even if one started with a nominal precipitation solution Ca/P 
molar ratio of around 0.5, the precipitates formed at or near the physiological pH 
would still be Ca-deficient apatitic CaP. C analyses proved that the precursor 
powders were carbonated, and the carbonate content decreased with an increase in 
the calcinations temperature, while the Ca/P molar ratio and the Na content 
remained almost the same.  
When the pH values of the same precipitation solutions were fixed at 
around 4.2, then the formed powders only consisted of the brushite phase (DCPD, 
CaHPO4.2H2O), whose XRD and FTIR data are not shown here to save space. 
The size and shape of those brushite crystals were also perfectly the same as 
mentioned elsewhere.72 The SEM morphology of the freeze-dried powders was  
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Fig. 5.1 (a) XRD traces and (b) FTIR traces of 37°C-heated and freeze-dried CaP 
gel precursors 
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Fig. 5.1 (c) & (d) SEM micrographs of freeze-dried CaP gel precursors at two 
different magnifications 
 
 
 
 
Table 5.1 Results of ICP-AES and C Analyses (in wt %, average of 3 runs) 
              Sample 
   Ca     P Ca/P (molar)  Na  C  CO3 
Freeze-dried 21.27 13.27 1.239 9.10 0.82 4.10 
300°C 28.93 17.99 1.243 8.98 0.58 2.90 
400°C 28.49 18.06 1.219 9.02 0.39 1.95 
500°C 28.36 17.88 1.226 9.35 0.32 1.60 
600°C 29.17 18.30 1.232 9.16 0.21 1.05 
1000°C 28.64 18.04 1.227 9.09 0.01 0.05 
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shown, at two different magnifications, in Figures 5.1c and d. The bright-field 
TEM photomicrographs given in Figures 5.2a and b depicted the nanostructure of 
the same powders. It should be noted that the selected-area electron diffraction 
inset of Figure 5.2b proved the nanocrystalline nature of those powders. 
TG/DTA/DSC analyses of the freeze-dried CaP precursors (Fig. 5.2c) indicated 
that upon heating to 155–160°C the samples first lost around 7.5% of their initial 
weight. This corresponded to the adsorbed water. Therefore, the water content of 
the precursor powders was deduced to be around 7 to 7.5%. With continued 
heating to 415°C, another gradual weight loss of about 2.5% was observed, and 
this was probably due to the volatilization of the remnants of nitrate ions. 
Characteristic IR bands for nitrate ions were to be found at 1440–1300 and 1070–
1030 cm-1,73 but in the IR spectra of Figure 5.1b it was quite difficult to identify 
those nitrate bands because of severe overlapping with the phosphate and 
carbonate bands over the same range. However, the weak bands at around 2200–
2030 cm-1 in Figure 5.1b can be ascribed to the nitrates.74 Further heating at above 
415°C, up to 650°C, displayed the removal of carbonate ions that was 
accompanied with a weight decrease of around 5 wt %, bringing up the total 
weight loss to 15%. The temperature when one reached constant weight was 
640°C (Fig. 5.2c).  
β-Rhenanite, i.e., β-NaCaPO4, phase in these gel precursors started to 
crystallize upon low-temperature calcination of the samples over the temperature 
range of 300–600°C. Especially, the DSC spectrum given in Figure 5.2c showed 
that there were two exothermic events taking place over the temperature range of 
440–570°C. The starting points of these exothermic events were indicated with 
arrows in Figure 5.2c. It should be noted that DSC is a dynamic process taking 
place at a heating rate of 5°C/min, and under isothermal heatings the starting 
points of those exothermic events would be slightly lower than those indicated by 
the TG/DTA/DSC spectra. XRD spectra of Figure 5.3a showed the crystallization 
of NaCaPO4 in a matrix of apatitic calcium phosphate. β-NaCaPO4 (sometimes it 
may also be written as CaNaPO4) has an orthorhombic (space group Pnam62) unit 
cell with the lattice parameters of a = 6.797, b = 9.165, and c =  
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Fig. 5.2 (a) & (b) TEM micrographs of freeze-dried CaP gel precursors and (c) 
shows TG/DTA/DSC spectra of freeze-dried CaP gel precursors - (a) 
TG, (b) DSC, and (c) DTA spectra.  
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5.406 Å.75 This phase (which will transform into α-NaCaPO4 at 650°C) is also 
isostructural with β-K2SO4. The most straightforward way of synthesizing phase-
pure NaCaPO4 powders can be the solid state reactive firing of the powder 
mixtures (in a 1:2:2 molar ratio) of Na2CO3, CaCO3, and (NH4)2HPO4 at 900–
950°C.75 However, such a synthesis route (which involves the formation of liquid 
phases upon melting of first (NH4)2HPO4 and then Na2CO3) will not be able to 
yield nanosize, therefore, high surface area and high surface reactivity powders.76 
The peaks denoted by * (and their respective hkl reflections) were those of β-
NaCaPO4, and the 2θ positions of such peaks were in close agreement with those 
given in ICDD PDF 29–1193. Upon heating at 600°C, CaP gel precursors of this 
study crystallized about 40 ± 3% β-NaCaPO4. This value was calculated from the 
data of Figure 5.3a by using the relative intensity ratio of the most intense peak of 
hydroxyapatite (at 31.78° 2θ) to that of NaCaPO4 (at 32.59° 2θ). The samples 
heated at 600°C for 6 h can therefore be named as 40% NaCaPO4–60% HA 
biphasic biomaterials.  
FTIR traces of the same calcined samples were depicted in Figure 5.3b. 
CaP precursors calcined even at the low temperature of 300°C were able to 
exhibit the characteristic OH- stretching vibration at 3572 cm-1, and this band 
became more pronounced with the increase in calcination temperature at or above 
500°C. The OH- bending vibration was also recorded at 634 cm-1.77 These bands 
proved that the freeze-dried apatitic calcium phosphate phase (which lacked the 
OH vibrations) present in the gel precursors completely converted into 
hydroxyapatite upon calcination. Precipitated apatitic calcium phosphate 
precursors need the humidity in the calcination atmosphere to transform into Ca–
hydroxyapatite upon heating.78–82 The relative humidity in our laboratories was at 
around 65–70% during those calcination runs. Characteristic FTIR spectrum of 
pure β-NaCaPO4 was previously given by Driessens et al.55 The orthophosphate 
stretching bands for the 500°C-calcined samples were observed at 603 (v4), 962 
(v1), 1020, and 1089 (v3) cm-1, which were contributed both by crystalline β- 
rhenanite and apatitic calcium phosphate.77 The absence of the P─O─P 
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Fig. 5.3 (a) XRD spectra of CaP gel precursors heated in air from 300°C to 
600°C (* and the respective hkl indices denote the reflections of β-
NaCaPO4, all the other peaks belong to HA); (b) FTIR traces of CaP gel 
precursors heated in air for 6 h from 300°C to 600°C 
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vibrational mode of pyrophosphates at 740 cm-1 (Fig. 5.3b) proved that the 
calcined samples did not contain any traces of Ca2P2O7.77 If the amount of HPO42- 
ions in the precursor powders were significant, then their conversion into 
pyrophosphate would have been inevitable through the reaction 2HPO42- → 
3P2O74- + H2O, which takes place at 600°C.31 Moreover, Loong et al.83 
definitively demonstrated the lack or significant deficiency of OH- ions occupying 
crystallographic sites in the Ca-deficient, non-stoichiometric apatitic crystals of 
rat and bovine bones by using inelastic neutron-scattering spectroscopy.  
It is known that an IR band at 1020 cm-1 can be attributed to the v3 
vibration of PO43- in non-stoichiometric or Ca-deficient and/or carbonated apatitic 
calcium phosphates; however, a band recorded at 1030 cm-1 is pinpointing to the 
v3 vibration of PO43- in stoichiometric hydroxyapatite.84 Therefore, the relative 
ratios of 1020/1030 bands in the FTIR spectra could provide a measure of mineral 
crystallinity and maturity in bone minerals or apatitic-looking calcium 
phosphates.77,85 While the samples calcined at 300°C or 500°C were displaying 
that orthophosphate v3 vibration at 1020 cm-1, the same vibration was found to 
shift to 1026 cm-1 in the 600°C-calcined sample (Fig. 5.3b). This can be ascribed 
to the transition from non-stoichiometric to stoichiometric apatite together with 
the crystallization of β-NaCaPO4 phase. On the other hand, it is interesting to note 
here that for the gel precursor samples dried at 37°C the same v3 vibration was 
recorded at 1027 cm-1, whereas the freeze-dried samples had it at 1020 cm-1, as 
shown in the IR traces of Figure 5.1b. This means that drying those gel precursors 
at 37°C for 72 h may have a positive effect on the progress of crystallization or 
so-called “maturation.”  
Variations in the grain size and morphology of the rhenanite-
hydroxyapatite biphasic powders, as a function of increasing calcination 
temperature, were monitored by the SEM micrographs given in Figure 5.4. The 
cracked-like grain/particle surfaces seen especially in the high magnification 
micrographs of Figure 5.4 are the artifacts created by the Pt-coating layer. Grain 
sizes directly measured from the SEM micrographs, as well as the respective 
surface areas of these powders, is given in Table 5.2.  
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Fig. 5.4  SEM morphology of freeze-dried CaP gel precursors heated: (a) & (b) at 
300°C; (c) & (d) at 400°C; (e) & (f) at 500°C; and (g) & (h) at 600°C     
(two different magnifications are reported) 
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Table 5.2 Grain Sizes and Surface Areas of Powders 
 
Sample Grain Size (nm) Surface area (m2/g) 
Freeze-dried 45 ±  10 128 ± 5 
300°C 60 ± 10 79 ± 4 
400°C 100 ± 10 70 ± 5 
500°C 150 ± 10 53 ± 3 
600°C 300 ± 70 34 ± 3 
 
 
 
Even after light calcination at temperatures from 300 to 600°C, these 
materials retained their initially small grain sizes still in the nano- or submicron-
range. These surface area data were quite comparable to those reported by 
Somrani et al.51 in a study on the thermal evolution of poorly-crystalline apatitic 
calcium phosphate powders produced by using Ca-nitrate tetrahydrate and 
diammonium hydrogen phosphate as the starting water soluble reagents, in the 
absence of any Na ions in their precipitation solutions. Apatitic calcium phosphate 
samples of Somrani et al.51 decomposed into crystalline tricalcium phosphate 
upon calcination. Freeze-dried samples of the current study consisted of (as 
shown in the micrographs of Figs. 5.1 and 5.2) particles (or moieties) having a 
needlelike morphology with average dimensions of 10 (thickness) and 70 (length) 
nanometer. These are very well within the size range of bone apatite crystals, 
which were documented by using electron microscopy for more than 5 decades 
ago.27,86 Johansen and Parks87 reported that bone apatite crystallites were platelike 
in shape with dimensions 400 x 200–350 x 25–50 Å. Upon calcination of the 
samples of this study, those initially plate- or needle-like, longitudinal moeities 
present in the freeze-dried powders (Figs. 5.1 and 5.2) tended to form more or less 
equiaxed or globular grains (Fig. 5.4). Such a tendency of nanosize globule 
formation upon heating can also be taken as a sign of those moieties (Fig. 5.2) 
actually being comprised of very much smaller particles. Indeed, early studies by 
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Molnar88,89 suggested that bone crystals are composed of chains of microcrystals 
fused in an end-to-end relationship. An X-ray diffraction study by Posner et al.90 
reported that the largest dimension of the bone apatite crystals was about 100 Å, 
and those apatitic crystallites should be regarded as a mosaic of microcrystals 
rather than as a continuously uniform, single crystal.31 The sodium-doped calcium 
phosphate gel precursors of this study [enthused by the work of Refs. 24, 48, 68] 
consisted of poorly-crystallized apatitic microcrystals very similar in dimensions 
and appearance to those of bone mineral.  
Nakahira et al.,91 in a study of testing the applied magnetic field on the 
bioactivity of  hydroxyapatite, reported the formation of NaCaPO4 as a second 
phase in 10% NaHCO3- mixed hydroxyapatite bioceramic samples upon sintering 
those at 1000°C. These authors blended the hydroxyapatite and NaHCO3 (at 10% 
level) powders by using a conventional ball-mill, followed by compaction, cold 
isostatic pressing, and sintering. Nakahira et al.91 also tested the bioactivity of 
those 1000°C-sintered samples by soaking them, at 37°C, in SBF 
(simulated/synthetic body fluid92,93) solutions from 4 to 7 days. It is quite 
interesting to note here that, under the identical SBF soaking conditions, 
according to Nakahira et al.,91 while the pure hydroxyapatite samples (with no 
magnetic field application) were not showing any bonelike CaP deposits on their 
surfaces, NaCaPO4-containing samples were covered with a high abundance of 
such deposits. This was again attributed to the higher bioactivity of NaCaPO4 
phase than that of pure hydroxyapatite.91,94 Although we did not include an SBF-
soaking study in this manuscript, the strong evidence brought upon by the work of 
Nakahira et al.91 was considered to be sufficient to ascertain the bioactivity (in 
SBF solutions) of such NaCaPO4-containing hydroxyapatite bioceramics. 
Moreover, the presence of Na ions that weaken the bond between Ca2+ and PO43- 
in the crystal surface accounts for the high dissolution rate of β-NaCaPO4. If the 
surface of a bioceramic sample inserted in an SBF solution exhibits such a 
significant ionic level dissolution phenomenon, then the Ca2+ and HPO42- ions to 
be abundant on these surfaces will further trigger the aggregation, and the 
consequent surface segregation, of Posner’s clusters found in those solutions.95  
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The NaCaPO4–HA biphasic powders of this study sintered well even after 
heating them at the low temperature of 1000°C for 6 h in air as pressed pellets. 
The SEM photomicrographs given in Figure 5.5a and 5b (insets showed a higher 
magnification view) depicted the surface of the well-densified pellets heated at 
1000°C for 6 hours after cooling at the rate of 5°C/min and 1°C/min, respectively. 
It is interesting to note that even the chemically synthesized, submicron HA-TCP 
biphasic powders do not show a densification rate (even after heating those at 
1200°C) as high as the samples of this study.96 Cooling rate was found to have a 
pronounced effect on the NaCaPO4–HA biphasic samples though. Samples cooled 
at the rate of 5°C/min (Fig. 5.5a) showed a larger number of both inter- and intra-
granular cracks, when the cooling rate was decreased to 1°C/min (Fig. 5.5b) those 
cracks were reduced. The mismatch between the coefficients of thermal 
expansion of NaCaPO4 and HA phases might be responsible for the formation of 
those cracks. Pellets sintered at 1000°C still had the same biphasic nature (i.e., 
60% HA - 40% NaCaPO4) and their XRD spectra were in strong resemblance to 
those given in Figure 5.3a for the 600°C-calcined powder sample. Sintering the 
biphasic samples at 1000°C for 6 hours did not destroy the original phase 
constitution. However, as expected, the FTIR spectra of the 1000°C-sintered 
pellets did not exhibit the carbonate bands. Carbonate ions in apatitic calcium 
phosphate structures cannot easily persist at temperatures greater than 700–
750°C. Nevertheless, a more detailed study of the sintering behavior of these 
biphasic powders, with the aim of forming dense, carbonate ion-free ceramics of 
low surface area, over the temperature range of >1000–1300°C was out of the 
scope of this study.  
β-NaCaPO4 phase was recently reported by El-Ghannam61 to form upon 
the calcination (180–800°C) of a new class of SiO2–CaHPO4.2H2O physically-
mixed powder blends initially wetted by rather concentrated NaOH solutions. In 
vivo studies performed by El-Ghannam61 found that these materials were superior 
to Bioglass® in terms of protein absorption, enhancement of bone generation, and 
overall resorption. Gong et al.60 reported that crystalline β-rhenanite in contact  
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Fig. 5.5  600°C-calcined biphasic powders sintered at 1000°C for 6 h and cooled 
at the rate of (a) 5°C/min and (b) 1°C/min 
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with SBF solutions may act as a nucleation precursor for the formation of apatitic 
calcium phosphates with respect to the following reaction: 
 
3NaCaPO4  + 2Ca2+ + H2O → 3Ca5(PO4)3OH  + 3Na+ + H+ (1) 
 
Kangasniemi et al.97 prepared _-rhenanite powders by sintering 
stoichiometric mixtures of CaHPO4 and Na2CO3 at 1300°C, followed by sieving 
the ground sintered chunks to a size below 45 µm, and used those later as 
crystalline additives (from 20 to 30 wt %) in their experimental bioactive glass 
compositions. The same authors were then reported in a separate study98 the 
dissolution behavior of crystalline β-rhenanite- or crystalline HA-containing 
bioactive glasses soaked in SBF from 5 h to 6 days. Kangasniemi et al.98 
concluded that the β-rhenanite-containing composites had a very positive effect 
on the rate of apatitic CaP layer formation on the surfaces of samples soaked in 
SBF.  
The earlier but quite comprehensive work of Ramselaar et al.54–56 should 
be taken as a good reference for the strong potential of β-rhenanite in developing 
resorbable or osteoinductive calcium phosphate bioceramics. The in vivo canine 
studies performed by Ramselaar et al.56 demonstrated that statistically more bone 
deposition occurred on β-rhenanite particles than on hydroxyapatite particles.  
This study showed that by simple calcination of a poorlycrystallized, Na-
containing calcium phosphate gel precursor synthesized at the physiological pH it 
will be possible to form biphasic biomaterials consisting of a high solubility β-
NaCaPO4 and less soluble nanosize hydroxyapatite. Since the starting material is 
a gel precursor, it can be easily shaped (for instance, by extrusion, injection 
molding or solid freeform fabrication techniques) into any desired three-
dimensional form before the full crystallization of the phases to take place during 
the final calcination step. The initial viscosity of such gels can be readily adjusted 
prior to the form fabrication. We have also observed that these gels can even be 
stored in ordinary zip-lock, air-tight nylon bags for more than a year (under 
refrigeration at 4°C), without resulting in any detectable changes in their XRD 
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and FTIR patterns. Moreover, leachable porogen phases or particulates (such as, 
NaCl, ammonium carbonate, ammonium acetate, ice crystals, etc.) may also be 
incorporated into these gels for forming porous bodies at the end of the 
fabrication processes. The only delicate step in the use of such preformed gels for 
forming 3D shapes would be the careful drying in a relative humidity controlled 
environment that should avoid the formation of drying cracks due to the rapid 
removal of entrapped water.  
The osteoinductive character reported99–101 for the biphasic β-TCP (40%) 
and HA (60%) biomaterials may also be expected for the β-rhenanite-HA 
materials of this study. Finally, to validate the above speculation and the clinical 
usefulness of the β-rhenanite + HA biphasic biomaterials of this work in vivo 
studies must be performed, which we plan to report in a follow-up study. 
 
5.4 Conclusions 
Sodium-doped calcium phosphate precursors were produced at room 
temperature by using a robust aqueous synthesis procedure involving the use of 
Na2HPO4, NaHCO3, and Ca(NO3)2.4H2O. The precursors formed at the 
physiological pH of 7.4 were in the form of a gel. Upon freeze-drying, these 
precursor gels were found to consist of poorly-crystallized, nanosize apatitic 
calcium phosphates with a surface area in excess of 120 m2/g. Calcination of these 
samples in a static air atmosphere over the temperature range of 400–600°C for 6 
h led to the production of β-rhenanite and hydroxyapatite biphasic biomaterials. 
Calcined powder samples had surface areas over the range 30 to 80 m2/g, and 
consisted of nanosize grains. 
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CHAPTER 6 
 
PREPARATION OF Zn-DOPED β-TRICALCIUM PHOSPHATE (β- 
Ca3(PO4)2) BIOCERAMICS 
 
Abstract 
Pure β-tricalcium phosphate (β-TCP) and Zn-doped (600, 2900, 4100, 7000, 9300 
and 10100 ppm) β-TCP samples were prepared by using a wet 
chemical/coprecipitation synthesis technique, followed by calcination at 1000°C 
in air. Precursor powders of the coprecipitation process were Ca-deficient 
nanoapatites (i.e., Ca/P molar ratio varying from 1.49 to 1.51) with needlelike but 
agglomerated particles of 30 nm thickness. In vitro culture tests performed by 
mouse osteoblast-like cells showed that the samples doped with 2900 to 4100 
ppm Zn showed the highest cell viability (via Live/Dead counts), and with a 
further increase in the Zn-content towards 1 wt% the number of dead cells in the 
well plates started to increase. Alkaline phosphatase (ALP) activity peaked for the 
β-TCP sample doped with 4100 pm Zn. The sample surface roughness, measured 
by non-contact profilometry, was also found to have an effect on the Live/Dead 
cell counts, and the highest cell viability encountered in this study corresponded 
to the surface with the least roughness. 
 
 
 
 
 
 
 
 
 
 
 
 
 
(This work is published in Mater Sci Eng C 27 (2007) 394–401) 
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6.1. Introduction 
The mineralized portion of human bones and teeth essentially consists of 
nanosize and imperfect crystals of Ca-deficient, carbonated and alkali- and 
alkaline earth-doped biological apatites.1 Bone apatites do not contain the β-
tricalcium phosphate (β-TCP: β-Ca3(PO4)2) phase. However, Mg-doped 
whitlockite, which can form in aqueous environments and structurally related to 
β-TCP, was found in human dental calculus2 and in carious lesions3,4. Human 
bone depositing cells, namely the osteoblasts, are not programmed to synthesize 
the β-TCP phase in their physiological habitat, pH and temperature. β-TCP is a 
calcium phosphate ceramic of high solubility in comparison to Ca-hydroxyapatite 
(HA; Ca10(PO4)6(OH)2). The solubility activity product (Ksp) of β-TCP is 2.51x10-
30,5, 6 whereas that of HA is 2.34x10-59 7. Owing to its significant solubility and 
ability of taking part in bone remodeling/turnover processes, β-TCP has become a 
bone substitute bioceramic in successful clinical use.8-10 Wiltfang et al.11 reported 
the in vivo resorbability (more than 95%) of β-TCP bioceramics in a minipig-tibia 
model observed over a period of 86 weeks. 
The human nutritional need for zinc is small, but its role in growth and 
well-being is enormous, starting even before birth.12 The entire body of a normal 
human weighing 70 kg may contain 1.4 to 2.3 g of zinc, and the recommended 
daily allowance of zinc is between 8 and 15 mg. Meats, seafood (especially 
oysters) and liver are the richest sources of zinc in food; brewer’s yeast, milk, egg 
yolks, popcorn, beans, cocoa, and wheat germ also supply some zinc.13 Zinc is 
found in body in small amounts in almost all tissues, however, the bones, teeth, 
and the pancreas contain slightly higher amounts than others. Human blood 
plasma contains approximately 1.5x10-2 mM of zinc.14 Zinc is an essential trace 
element in a variety of cellular processes including DNA synthesis, behavioral 
responses, reproduction and virility, bone formation, bone growth and wound 
healing.15 Zinc plays an important role in gene expression and in the regulation of 
cellular growth and differentiation,16 since it participates as a co-factor of more 
than 200 enzymes implied in the metabolism of nucleic acids, carbohydrates and 
proteins. Approximately 85% of the body store of zinc is found in skeletal 
  
 
119
muscles (55%) and bones (30%).17 The necessity of this trace element for bone 
growth was demonstrated by the observation that normal bone growth was 
retarded in animals that are zinc-deficient,18 and the addition of zinc to these 
deficient diets resulted in a stimulation of both bone growth and mineralization.19 
Zinc is the only metal to be incorporated in all six enzyme classes of 
metalloenzymes, with the examples of oxidoreductase, transferase, hydrolase, 
lyase, isomerase, and ligase activity.20 Important bone enzymes, including 
alkaline phosphatase (ALP) and carbonic anhydrase are zinc metalloenzymes, and 
tartrate-resistant acid phosphatase (TRAP) is strongly inhibited by zinc 21, 22. In 
brief, zinc deficiency has been associated with skeletal growth retardation, 
reduced ALP activity18, reduced premenopausal bone mass23 and postmenopausal 
osteoporosis24. Clinical trials have also shown that zinc supplementation inhibits 
postmenopausal bone loss 25. Zinc has been implicated in bone formation, 
mineralization,26 and the stimulation of ALP activity in calvarial organ cultures,18, 
27 osteoblast-like cell cultures,28-30 as well as the stimulation of the bone DNA 
synthesis via the activation of bone DNA polymerase31. Zinc deficiency, on the 
other hand, were recently shown to cause about 300% increase in programmed 
cell death (or apoptosis) in mice in a variety of kinds of cells32, and insufficient 
zinc initiated apoptosis in hepatocytes, glioma, kidney, monocytes, fibroblasts, 
and testicular cells. 
To the best of our knowledge, a thorough investigation on the synthesis of 
Zn-doped HA and/or TCP bioceramics has a rather short history. Fuierer et al.33 
and Bigi et al.34 performed the pioneering studies in this field, which reported the 
inhibiting effect of zinc on HA crystal growth in aqueous systems. A later report 
by Bigi et al.35 attempted to synthesize Zn-doped β-TCP bioceramics at Zn 
dopant levels from 2.5 to 20 mole%, with increments of 2.5 mole% over this 
range.  Bigi et al.35 first prepared single-phase β-TCP ceramics by calcining a 
stoichiometric powder mixture of CaHPO4⋅2H2O and CaCO3 at 1000°C for 15 h. 
To produce the Zn-doped β-TCP bioceramics, Bigi et al.35 mixed the phase-pure 
β-TCP powders with those of α-Zn3(PO4)2 and calcined the resultant mixtures at 
1000°C for 15 h. Bigi et al.35 concluded that the small Zn ion (0.074 nm) readily 
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replaced the larger Ca ion (0.099 nm) in the β-TCP structure (rhombohedral, 
space group R3c), causing a steady and monotonic decrease in the a-axis of the 
unit cell from 10.44 to 10.325 Å, while causing a slight decrease in the c-axis 
length from 37.41 to 37.25 Å, with isomorphic Zn substitution from 2.5 to 20 
mol% over the Ca-sites. LeGeros36, 37 has been the first to report the formation of 
TCP phase (together with needle-like apatite crystals) in aqueous solutions 
containing zinc. The last five years have seen a number of publications38-51 
coming from the laboratory of Dr. Atsuo Ito, all concerning with the synthesis 
and/or in vitro-in vivo testing of Zn-containing calcium phosphate ceramics. In 
some studies of the Ito group, the ZnTCP samples (to be later blended with HA 
powders) were prepared by the Ca(OH)2-H3PO4 neutralization route with the 
addition of zinc nitrate into those solutions to obtain 10 to 30 mol% Zn doping,39 
while in some studies by Layrolle et al.52 a sol-gel route, which used Ca(OEt)2 
(obtained from the reaction of Ca metal shots and ethyl alcohol), H3PO4 and Zn-
acetate, was employed to synthesize the samples. The Ito group synthesized 
numerous calcium phosphate samples by doping Zn starting from 600 ppm level 
up to 10-20 mol%.48 However, most of the studies of this group were focused 
more on the in vivo and in vitro testing of ZnTCP-HA biphasic samples. 
Therefore, the reports originating from the Ito group which focused only on the 
testing of Zn-doped β-TCP (i.e., without any HA) 41, 45, 50, 51 are in direct relevance 
with the present study. However, in these studies the following points can be 
underlined: (i) their powder samples were produced by using the Ca(OH)2-H3PO4-
Zn-nitrate synthesis route,41, 45, 50, 51 (ii) when the authors were adding 12 mol% 
Zn, their samples were reported to contain the phase of CaZn2(PO4)2,51 (iii) the 
authors first synthesized 10 mol% ZnTCP powders and then mixed those in a 
mortar with pure β-TCP powders to obtain 0.28, 2.56, 5.0, 7.47, and 10.5% Zn-
containing ZnTCP samples after calcination at 1000°C,45 (iv) when the authors 
were preparing the so-called 12 wt% Zn-containing ZnTCP samples, they 
reported to have the secondary phases of Ca2.7Zn0.3(PO4)2 and CaZn2(PO4)2, 41, 50 
(v) the authors never cited the important work of Bigi et al.35 and compared their 
findings with those reported before, (vi) the authors did not study the low end of 
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the Zn-doping range. The goals of the present study can be briefly stated as 
follows; (i) to develop an aqueous co-precipitation process (incorporating a 
calcination step; at 1000°C) for synthesizing Zn-β-TCP samples with Zn levels 
ranging from 600 ppm to about 1.0 wt% to eliminate the need for physical mixing 
of more than one powders to produce Zn-doped calcium phosphate bioceramics, 
(ii) to characterize the samples by using XRD, FTIR, TGA, ICP-AES, density and 
surface profilometry measurements, (iii) to test the cytotoxicity and ALP (alkaline 
phosphatase) activity of the Zn-β-TCP samples (600, 2900, 4100, 7000, 9300 and 
10100 ppm Zn)  by using rat osteoblast-like cells. 
 
6.2. Experimental Procedure 
6.2.1 Sample preparation. Ca(NO3)2⋅4H2O (>99.5%, Fisher), NH4H2PO4 
(>99.5%) and Zn(NO3)2⋅6H2O (>99.9%) were the starting chemicals used in 
powder synthesis. α-Zn3(PO4)2 powder (TZP; 99.995%, #13013) was provided by 
Alfa-Aesar Inc. Briefly, NH4H2PO4 was dissolved in deionized water in a glass 
beaker, and in a separate beaker Ca(NO3)2⋅4H2O and Zn(NO3)2⋅6H2O were 
dissolved in proper amounts. Ca-Zn-nitrate mixed solution was then added at once 
into the phosphate solution, the slight turbidity instantly observed was eliminated 
by adding few drops of concentrated HNO3 (69 vol%, Fisher) which also brought 
the solution pH down to 3±0.1 from around 4, and therefore, a clear solution was 
obtained. This solution was stirred (200 rpm) at 37°C for 2 h to ensure a 
homogeneous mixture, followed by rapidly adding about 50 mL of a concentrated 
NH4OH (29% NH3, Merck) solution to obtain precipitation and a stable pH value 
of around 9.2 ±0.2 again at 37°C. The opaque solution was stirred for 1 h. Formed 
precipitates were filtered (paper No. 42) via a Buechner funnel, washed with 4 L 
of water, and then dried at 90°C for 12 hours in air in glass dishes. Dried powders, 
which were free of hard agglomerates, were only lightly ground in an agate 
mortar by a pestle. Precursor powders were uniaxially pressed (3580 kg/cm2) into 
1.5 mm-thick, 1.27 cm-diameter pellets in steel molds and then calcined in air at 
1000°C for 6 h in clean Al2O3 boats or crucibles (heating/cooling rate: 3°C/min).  
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Table 6.1 Powder synthesis procedure 
 
 
a ppm Zn in β-TCP, measured by ICP-AES in powder samples calcined at 1000°C 
for 6 h 
b ICP-AES analyses of powder samples calcined at 1000°C for 6 h 
 
 
 
TZP powders were also pressed into pellets and later calcined in the way as 
described above. The details of powder syntheses were given in Table 6.1, in 
which the samples of interest were named according to their experimentally-
determined (by ICP-AES) ppm Zn values after calcination.  
6.2.2 Characterization. Chemical analyses of powder (both precursor and 
calcined) samples were performed by ICP-AES (Model 61E, Thermo Electron, 
Madison, WI). During the ICP-AES analyses, 50 mg portions of powder samples 
were dissolved in 5 mL of concentrated HNO3 solution. Surface roughness of the 
calcined Zn-β-TCP pellets were measured, prior to cell culture tests, by a non-
contacting surface profilometer (NT-2000, Wyko, Tucson, AZ) at the 
magnification of 25 X and over a 164 x 215 µm field of view. In profilometry, Rt 
was the maximum height minus the minimum height in the field of view, whereas 
Rz was the average of 5 highest peaks minus the average of 5 lowest valleys. Bulk 
densities of the calcined pellets (repeated 5X) were measured by using a 
pycnometer (AccuPyc 1330, Micromeritics, Norcross, GA) with He gas. 
For the phase analyses of powder samples an X-ray diffractometer (XRD; 
XDS 2000, Scintag Corp., Sunnyvale, CA) was used (Cu Kα radiation at 40 kV 
and 30 mA, with a step size of 0.03° and preset time of 1 s at each step). Samples 
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were also analyzed by FTIR (Nicolet 550, Thermo-Nicolet, Woburn, MA). 
Scanning electron microscopy (FE-SEM; S-4700, Hitachi, Tokyo) was used in the 
secondary electron mode with an acceleration voltage of 5 kV to image the 
samples. 
6.2.3 In vitro cell culture tests.  Statistical sample size (i.e., n) was 16 in the 
entirety of the cell culture tests.7F2 rat osteoblast-like cells (CRL-12557, 
American Type Culture Collection, Rockville, MD) were grown on 75 cm2 
culture flasks at 37ºC and 50% CO2 in α-MEM with 2 mM 1-glutamine and 1 
mM sodim pyruvate without ribonucleosides and deoxyribonucleosides, 
augmented by 10% FBS. The culture medium was changed every other day until 
the cells reached a confluence of 90-95%, as determined visually with an inverted 
microscope. The cells then were passaged using trypsin (2.5 g/L)/ EDTA (25mM) 
solution (Sigma-Aldrich Corp., St. Louis, MO, USA). The obtained cells were 
then seeded at a concentration of 3500 cell/well on 0.14 cm3 samples for various 
assays. Cell viability and alkaline phosphatase activity measurements were 
performed after 72 hours. The cell viability assessment was performed using 
Live/Dead® Viability/Cytotoxicity Kit (L-3224, Molecular Probes, Eugene, OR). 
A working solution is prepared by mixing 5µl aliquot of Component A (4 mM 
calcein AM solution in DMSO) to 10 ml of 4 mM EthD-1 solution (20 µl of the 
Component B to 10 ml of DPBS). 100 µl of this working solution was added to 
the cell-containing samples along with 100 µl of cell-containing media. Samples 
were incubated at room temperature for 30-45 minutes. After the prescribed time 
period, the fluorescence values were recorded at 494/517 nm for live cells and 
528/617 nm for dead cells by using a standard curve obtained by seeding different 
number of cells in different wells. The alkaline phosphatase (ALP) activity was 
determined using the ALP concentration and the cell extracted protein 
concentration. The ALP concentration was calculated using Enzymatic Assay of 
Phosphatase Alkaline Kit (EC 3.1.3.1, Sigma-Aldrich Corp., St. Louis, MO, 
USA). A working reagent was prepared by first mixing 2.7 ml of Reagent A (1.0 
M Diethanolamine Buffer with 0.50 mM Magnesium Chloride) with 0.30 ml of 
Reagent B (150 mM p-Nitrophenyl Phosphate Solution (pNPP)) and then mixing 
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the mixture with 0.10 ml of cell-containing media. 100 µl of this solution was 
added to each well and thoroughly mixed and incubated at 37ºC for 30 minutes. 
Following incubation, the absorbance was recorded at 405 nm with the 
spectrophotometer at room temperature. The standard curve was obtained by 
plotting the absorbance measured at 405 nm for certain concentration against the 
concentration in µg/ml. ALP concentration of each sample was then determined 
using this standard curve and is expressend as µg-pNP/ml. The cell extracted 
protein concentration was determined in a two-step procedure, first the protein 
was extracted using M-PER™ Mammalian Protein Extraction reagent and then 
this extracted protein was measured using BCA™ Protein Assay Kit. The cell 
samples were lysed by adding 200 µl of M-PER™ Reagent to each well plate and 
then shaking for 5 minutes. Lysate was collected and transferred to 
microcentrifuge tubes, followed by centrifuging at 4000g for 10 minutes to pellet 
the cell debris. Supernatant was transferred to clean tubes for analyzing the 
protein concentration. To measure the protein amount, a working reagent (WR) 
was prepared by mixing 50 parts of BCA™ Reagent A with 1 part of BCA™ 
Reagent B (50:1, Reagent A:B). 200 µl of the above mentioned WR was added to 
each well and thoroughly mixed. Following mixing, the well plate was covered 
and incubated at 37ºC for 30 minutes. The absorbance at 562 nm was measured 
with the spectrophotometer at room temperature. A standard curve was prepared 
by plotting the average blank-corrected 562 nm measurement for each BSA 
standard versus its concentration in µg/ml. Cell extracted protein concentration 
was then determined by using this standard curve and is expressed as µg/ml. The 
ALP activity was then calculated as follows; ALP Activity = [(µg pNP)/139] / 
µg(cell extracted protein) =  µmoles pNPP/ µg cell protein. Osteoblast 
attachment/proliferation on the pellets was studied using SEM. Cells were first 
fixed by using 3.5% glutaraldehyde, and then dehydrated through sequential 
washings in 50%, 70%, 95% ethanol solutions and 2 times in 100% ethanol. 
Samples were then critical point-dried, prior to sputter-coating with a thin layer of 
Pt.  
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6.3. Results and Discussion 
The pure and Zn-doped precursor powders of this study gave the same 
XRD pattern as shown in Figure 6.1a, which belonged to that of Ca-deficient 
apatitic calcium phosphate (CDHA: Ca9(HPO4)(PO4)5OH). Yubao et al.53 
previously called this phase as apatite-TCP and gave a full account of its crystal 
structure. Rietveld refinement of the structure of CDHA was performed by 
Ivanova et al.54 and Tas et al.55. Gibson et al.,56 on the other hand, studied the 
thermal transformation of CDHA into β-TCP. FTIR spectra of the precursor 
powders were given in Figure 6.1b, while the ICP-measured Zn levels (in ppm) 
were indicated on the diagram. The vibrations indicated in Figure 6.1b with 
arrows denoted the OH vibrations, whereas the rest indicated the characteristic 
PO43- and CO32- vibrations.56  
It should hereby be noted that there was a difference between the ppm Zn 
levels achieved in the powders before and after calcination (see Table 6.1). This 
was believed to be due to the difference(s) in surface adsorbed or in hydroxide-
form Zn (i.e., in precursor powders) and the structure-assimilated Zn ions (i.e., 
after heating). Calcination, and therefore, the solid-state diffusion apparently had 
a certain effect on the stabilization of the final Zn content of the samples. 
According to the ICP-AES results of the precursors and the calcined samples, 
vaporization of Zn was not observed during calcination. TGA traces of the 
precursors (Fig. 6.1c) showed, from RT to around 500°C, an initial weight loss 
between 4 to 9%, which corresponded to the loss of surface adsorbed water and 
probably some residual ammonium and nitrate ions.54 The unique shoulder 
observed at around 720°C in Figure 6.1c represented the volatilization of 
carbonate ions. Carbonated nature of these precursor powders were also detected 
by their FTIR spectra of Figure 6.1b. It was difficult to find a direct correlation 
between the TGA weight loss behavior and the Zn-dopant level. The high-
magnification SEM micrographs given in Figure 6.1d were recorded directly on 
the surface of a green pellet prepared from 8700 ppm Zn-containing TCP 
precursors, and the same morphology was also observed on 600 ppm Zn-
containing precursors (data not shown). Micrographs of Figure 6.1d confirmed (as  
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(a)            (b) 
 
   
(c)            (d) 
 
 
Fig. 6.1 Precursor samples (a) XRD spectra; (b) FTIR spectra; (c) TGA traces; 
and (d) SEM micrographs (inset shows high magnification). 
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did Fig. 6.1a) the nanocrystalline nature of these precursors, and the powders 
consisted of acicular particles of about 100 nm-long and 30 nm-thick. TEM 
studies are underway. Apparently, uniaxial pressing of those powders into a pellet 
at 3580 kg/cm2 forced them to pack closely. 
Calcination of the pure and Zn-doped precursor powders at 1000°C 
resulted in the complete transformation of CDHA into β-TCP and Zn-doped β-
TCP. The Zn-content and Ca/P molar ratio of the calcined pellets were depicted in 
Table 6.1. The XRD (Fig. 6.2a, Zn-content in ppm values were indicated on the 
traces) and FTIR (Fig. 6.2b) spectra of the calcined samples confirmed the 
formation of β-TCP. The small extraneous peaks in Figure 6.2a, labeled by 
asterisks in the traces of 7000 and 9300 ppm Zn-containing samples, 
corresponded to the very strong 211 reflection of the HA phase. In reproduction 
runs for the samples these peaks were not observed, but we decided to report here 
the original data. This probably showed an inherent limitation of our synthesis 
procedure in producing 100% pure β-TCP. 
Calcination of the precursors in an air atmosphere (at uncontrolled relative 
humidity levels from one experiment to the other) may also be influential on this 
point of HA formation. Surface profilometry data shown in Figure 6.2c indicated 
to an interesting decrease in surface roughness at around 2900 and 4100 ppm Zn-
content, with increasing or decreasing Zn-dopant level surface roughness 
increased. The surface morphology of a pure β-TCP calcined pellet was given in 
Figure 6.2d, grain sizes ranged from 350 nm to 2 µm. However, the grain size 
distribution in 2900 and 4100 ppm Zn-β-TCP samples were quite different from 
that of pure β-TCP, as shown in Figures 6.2e and f, respectively. The significant 
increase in the average grain size of the 4100 ppm Zn-β-TCP sample should also 
explain for the dip in the surface profilometry results given in Figure 6.2c. The 
slight decrease in the average grain size in the 10100 ppm Zn-β-TCP sample (Fig. 
6.2g) was interesting to note. These data showed that Zn was also an effective 
dopant in altering the grain boundary area in this new class of β-TCP samples. 
The progressive Zn doping caused a decrease in the bulk density of the pellets 
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calcined at 1000°C, as shown in Table 6.2. The density data of Table 6.2 
represented densification in excess of 95% of the theoretical density of β-TCP. 
The 600 ppm Zn-β-TCP sample had the formula Ca2.997Zn0.003(PO4)2, whereas the 
formula for the 10100 ppm sample was Ca2.952Zn0.048(PO4)2. The TZP pellet, 
which was used as a control in the cell culture tests, showed the polymorphic 
transformation from the α- (ICDD PDF 29-1390) to the β-form (ICDD PDF 30-
1489) upon calcination at 1000°C (XRD and FTIR data not shown). This 
polymorphic transformation in TZP was known to occur above 942°C. 
The results of culture tests with mouse osteoblast-like cells were 
summarized by the histograms given in Figures 6.3a (Live/Dead cytotoxicity) and 
6.3b (ALP activity). Taking into consideration the rather significant length of the 
error bar on the 2900 ppm Zn sample in Figure 6.3a and the highest ALP activity 
observed for 4100 ppm Zn sample (Figure 6.3b), it can be stated that the 
maximum proliferation of the osteoblast-like cells was recorded on the 4100 ppm 
Zn-β-TCP sample of this study. It will also be interesting to couple this finding 
with the fact that the minimum surface roughness (Figure 6.2c) and the maximum 
bulk density (Table 6.2) values of this study were observed for the very same 
4100 ppm Zn-β-TCP sample. β-TZP was found to be a perfectly cytotoxic 
material (Figure 6.3a). It also became apparent that, in comparison to pure β-TCP, 
the presence of Zn especially at the dopant levels of 2900, 4100 and 7000 ppm 
significantly increased the osteoblastic activity (Figs. 6.3a and b).57 This point is 
in very well agreement with the previous literature cited in Section 2. The 
attachment and spreading of osteoblasts on various Zn-β-TCP pellets were 
imaged by SEM and given in Figure 6.4. On pure β-TCP pellets, osteoblasts 
spread like a thin, electron-translucent membrane so that the underlying grains 
were still visible (Fig. 6.4a). The erosion of the grain boundaries (Fig. 6.4a) 
during the cell culture tests may indicate that there might have been a highly 
soluble amorphous CaP grain boundary phase which dissolved under the alkaline 
phosphatase 
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Fig. 6.2 Calcined samples (a) XRD spectra; (b) FTIR spectra; (c) Surface 
profilometry. 
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Fig. 6.2  SEM micrographs of calcined samples (d) 0 ppm (pure β-TCP), (e) 2900 
ppm, (f) 4100 ppm,  and (g) 10100 ppm Zn-βTCP. 
 
 
 
Table 6.2    Bulk densities of Zn-doped β-TCP pellets 
 
 
 
 
A        B
C        D
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Fig. 6.3 (a) Live/Dead (cytotoxicity) data and (b) ALP activity data for Zn- doped 
β-TCP. 
 
 
 
   
 
   
 
Fig. 6.4 SEM micrographs of osteoblast cells on (a) 0 ppm (pure β-TCP), (b) 
2900 ppm, (c) 4100 ppm, and (d) 7000 ppm Zn-β-TCP pellet 
 
A        B
C        D
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enzyme activity. The 2900 ppm Zn-containing sample surfaces (Fig. 6.4b) 
showed a high degree of osteoblast coverage, and the inset in Figure 6.4b 
displayed quite a significant degree of cell spreading. The cell nuclei became 
visible even by the SEM images on 4100 ppm Zn-containing β-TCP samples (Fig. 
6.4c). Typically, such imaging of cell nuclei could be achieved by using 
fluorescent microscopy together with special histological staining practices. In 
this case (i.e., 4100 ppm Zn), the cells were also proliferating into cytoskeletal 
stress fibers beyond extending their filopodia. When the Zn-content was increased 
to 7000 ppm (Fig. 6.4d), the cell attachment and spreading was still at quite high 
levels. On the surfaces of β-TZP samples, it was not possible to find even a single 
cell to image by the SEM, confirming the cytotoxicity results of Figure 6.3a.  
Although the sample preparation routes of the two studies differed from 
one another significantly, the findings of the present work enhanced those of Ito et 
al.,45 especially at the ppm level Zn-doping into β-TCP. In vivo resorbability of 
the samples of this study must be tested. The search for more reliable ways of Zn-
doping in calcium phosphates (HA, TCP or biphasic HA-TCP) and the in vitro 
and in vivo characterization of the resultant samples seems to be an exciting field 
of biomaterials research.58-62  
 
6.4. Conclusions 
(1) Aqueous co-precipitation was used for synthesizing ppm-level Zn-doped β-
TCP precursor nanopowders. This method was suitable to produce 600, 2900, 
4100, 7000, 9300 and 10100 ppm Zn-containing β-TCP samples after calcination 
at 1000°C for 6 hours in air. 
(2) Zinc was found to influence the grain growth characteristics and densification 
of β-TCP samples. 4100 ppm Zn-doped β-TCP sample was observed to have the 
highest bulk density within the range of dopant levels studied in this work. 
(3) In vitro cell culture tests performed with mouse osteoblast-like cells showed 
the significant effect of ppm level presence of Zn in β-TCP samples in enhancing 
the osteoblastic activity, in direct comparison to pure β-TCP and β-TZP. The 
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Live/Dead cytotoxicity counts and alkaline phosphatase activity data were 
collected for all the samples.  
(4) Live/Dead counts were peaked for the 2900 ppm Zn-β-TCP samples, whereas 
the ALP activity was found to be the highest for the 4100 ppm Zn-containing β-
TCP samples. 
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CHAPTER 7 
 
ENHANCED BIOMIMETIC COATING OF COLLAGEN AND ITS IN 
VITRO EXAMINATION 
 
Abstract 
Coating porous collagen membranes via a biomimetic method with a layer of 
carbonated apatitic calcium phosphates was performed in this study. The 
biomimetic process involves soaking the substrates in a simulated body fluid 
(SBF) solution. The goal of this research was to enhance process kinetics of 
biomimetic coating process by employing novel composition of SBF. For this 
purpose, an improved version of SBF solution (tas-SBF, hereafter referred to as t-
SBF) was employed and is a TRIS-HCl buffered solution with a HCO3- ion 
concentration of 27 mM. With the use of t-SBF, apatitic calcium phosphate 
coatings homogeneously covered the collagen surface were performed over a 7 
day period. This is a significant enhancement in the coating kinetics as opposed to 
previous attempts. All samples were characterized by X-Ray Diffraction (XRD), 
Fourier Transformed Infrared (FTIR) spectroscopy, and Field-Emission Scanning 
Electron Microscopy (FE-SEM). Mouse osteoblasts (7F2) were used to compare 
in vitro response of untreated collagen and SBF-coated collagen membranes via 
the alkaline phosphatase activity, cell density and cell proliferation tests. These in 
vitro results showed a more favorable response to the apatitic calcium phosphate 
coating over the untreated collagen membrane. 
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7.1. Introduction 
A composite of collagen and apatite is of special interest because of their 
compositional similarity with bone.1-4 In recent years, there is an increased effort 
to produce apatite-collagen composite materials by innovative biomimetic 
processing.4-11 Biomimetic coating process is employed to coat collagen 
substrates to synthesize the apatite-collagen composites.12-20 This coating process 
involves soaking the substrate in a supersaturated or metastable solution at human 
body temperatures (37°C), which in turn forms several-micron-thick bioactive 
layers of apatitic calcium phosphate nano-aggregates. It has been determined that 
acellular physiological solutions such as synthetic or simulated body fluid (SBF) 
solutions are able to induce such bioactive apatitic calcium phosphate layer on 
metals, ceramics, and polymers (with proper surface treatments).21-23  
SBF solutions maintain physiological conditions and are able to mimic the 
ionic concentrations of human plasma. In 1990, Kukubo popularized one such 
composition known as conventional simulated body fluid or “c-SBF”.21 However, 
one disadvantage of c-SBF is that it contains lower carbonate ion concentration 
than human plasma. In 1999, Tas et al.24, 25 increased the carbonate ion 
concentration in a TRIS-HCl buffered SBF solution (tas-SBF, hereafter referred 
to as t-SBF) to 27 mM (same as that of human plasma) while Bigi et al.26 did 
similar experiments using a HEPES-NaOH buffered SBF solution. Kokubo et al.27 
later increased the carbonate ion concentration of their c-SBF solutions from 4.2 
to 27 mM by using HEPES-NaOH buffer and named it “revised-SBF” (r-SBF). A 
detailed historical development of acellular physiological solutions since 1882 has 
been summarized by the present authors elsewhere.28 The following sections 
provide a brief review of biomimetic coating of collagen. 
7.1.1  Biomimetic Coating of Collagen – A Brief Review 
It is reported in the literature that the biomimetic coating kinetics of 
collagen is very slow.14 Even after 4 weeks of soaking time, the collagen surface 
was not fully covered by apatitic calcium phosphates.13 Several studies indicate 
that an increase in the bioactivity of collagen can be achieved by modifying the 
normal soaking procedures.12-20 These methods include either changing the 
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chemistry of collagen or adding a compound to c-SBF solutions. Rhee et al.12 
performed their experiments by soaking the collagen in SBF solutions with and 
without citric acid. Although citric acid is known to be an inhibitor of calcium 
phosphate formation,29 they determined that carbonated apatitic calcium 
phosphates formed only on collagen in the SBF solution with an addition of citric 
acid.12 The investigation of nucleation of apatite by the same authors indicated 
that the coating is critically dependent on the carboxylate group of collagen.13 
These results were later substantiated by Zhang et al.,14 who studied the growth of 
apatitic calcium phosphates on the collagen membrane by phase-contrast 
microscopy. They suggested that the charged functional groups of collagen 
membranes play a key role in the growth of apatitic calcium phosphates.14 Several 
theories were proposed to explain the formation of apatite layer on materials 
soaking in an SBF solution. It was hypothesized that the apatite layer forms when 
the material surface is negatively charged13, 30 and/or when silanol groups1,31 are 
present on the surface. Chemical treatment by soaking the collagen discs in TEOS 
at room temperature for 1h was performed by Andrade et al.15. This treatment 
formed a silica coating on the collagen surface resulting in a negative charge upon 
contact with the SBF solution, thus increasing the bioactivity.15 In 10 days, the 
surface was not fully covered and the underlying collagen fibers were still 
visible.15 Lickorish et al.16 deposited apatitic calcium phosphates on collagen by 
soaking them in SBF in the presence of calcium silicate glass. They used two 
different solutions, a nucleation solution and a growth solution. The nucleation 
solution was formed by dissolving calcium silicate in SBF and a growth solution 
was just SBF solution.16 The calcium silicate glass played an important role in 
initiating apatite deposition on collagen substrates because when no glass was 
present in the nucleating solution, apatite deposition failed to occur even after 
soaking in the growth solution for 11 days. These findings support the hypothesis 
of deposition via silanol mechanism. In this process, as reported in ref.,16 a 
uniform thin coating of calcium phosphate forms on collagen after approximately 
a total of 2 weeks of soaking time. The role of phosvitin on the nucleation of 
apatitic calcium phosphates on collagen was investigated by Kobayashi et al.17 by 
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forming a collagen-phosvitin composite. They found that the rate of calcium 
phosphate nucleation is enhanced in the presence of phosvitin, and also 
hypothesized that phosvitin controlled the orientation of the precipitated calcium 
phosphates.17 Li et al.18 demonstrated the fabrication of three dimensional 
collagen/wollastonite composites using freeze-drying methods. These 
collagen/wollastonite composites exhibited better deposition of apatitic calcium 
phosphates after soaking in SBF for 7 days and the surface was uniformly covered 
in 15 days, thus decreasing the coating time.18 Eglin et al.19 prepared collagen 
hydrogel containing bioactive glass (CaO-P2O5-SiO2) and silica sol-gel particles 
and studied their in vitro apatite-forming ability in SBF solution. The silica-
collagen hydrogel composite precipitated calcium phosphate whereas silica 
particles and collagen hydrogel alone did not, indicating a possible synergistic 
effect between the collagen and silica on the apatite-forming ability.19 The 
bioactivity of the nano-HA-collagen composite was also investigated by Lin et al. 
20. Their results show that the composite was coated with apatitic calcium 
phosphates after 2 weeks of soaking in SBF.20 From these reported studies, it can 
be concluded that modification of collagen or addition to SBF increases the 
kinetics of the coating process and homogeneous coating of the collagen surface 
in c-SBF takes at least 1-2 weeks. Even after modification, this process appears 
lengthy as the dissolution of collagen in the liquid medium poses a relevant issue. 
In view of these findings and the evolution of r-SBF27 with 27 mM HCO3- 
concentration, attempts by Girija et al. were made to coat collagen in r-SBF.32 r-
SBF showed improvement in coating rate and was able to coat the collagen in just 
2 weeks without any modification to either collagen or SBF.32 The reported SEM 
micrographs show that the morphology of the apatitic calcium phosphates 
deposited on the collagen substrate by r-SBF differed from those formed by c-
SBF. The same features are reported by Bigi et al.26 that showed the spherical 
aggregates instead of nano-needles or nano-platelets morphology on gelatin films. 
In order to further increase the coating rate, the presence of polyacrylic acid 
(PAA) in collagen and in SBF was examined.33 The results showed that PAA not 
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only affected the microstructure of apatitic calcium phosphates but their 
mineralization as well.33  
7.1.2 Effects of Various Coating Parameters on Coating Rate and 
Morphology 
As previously reported, the coating rate was slow when collagen was 
soaked in c-SBF, even with modifications. The reason for the slow apatite 
inducing ability of c-SBF is due to the low HCO3- concentration. A study by 
Dorozhkina et al.34 emphasized the influence of HCO3- concentration in a TRIS-
free SBF solution on the morphology and thickness of calcium phosphate coatings 
formed. They discovered an increase of the HCO3- concentration in c-SBF from 
4.2 to 27 mM resulted in the formation of homogeneous and much thicker 
carbonated hydroxyapatite layers.34 Similar results were obtained by Jalota et al.28 
where they compared the coating abilities of TRIS-HCl buffered SBF solutions of 
4.2 mM and 27 mM HCO3- concentration. They discovered that a t-SBF solution 
with a HCO3- concentration of 27 mM was able to coat the titanium strips faster 
than c-SBF solutions with a concentration of 4.2 mM HCO3-.28 Thus, in order to 
increase the kinetics of the coating process in collagen, the present authors 
suggest increasing carbonate ion concentration to 27 mM of the SBF.  
A morphological difference was observed in the coatings produced by r-
SBF in comparison to those in c-SBF. This difference was also observed on 
Ti6Al4V substrates in a recent study, where 27 mM HCO3- concentrated TRIS-
HCl buffered (c- and t-) and HEPES-NaOH buffered (r-) SBF solutions were 
compared.28 c-SBF and t-SBF solutions always produced round globules 
consisting of intermingled nano-needles of calcium phosphates on Ti6Al4V strips 
whereas r-SBF solutions produced nearly spherical aggregates.28 This 
morphological difference between these SBF solutions is possibly due to 
differences in the buffer used for preparation. Dorozhkina et al.34 emphasized that 
HEPES was rather unstable, in comparison to TRIS, and that it easily loses some 
of the initially present dissolved carbonates. Kokubo et al.,35 who developed the 
HEPES-buffered r-SBF composition, also reported that r-SBF would release CO2 
gas from the fluid. During longer storing periods, there was a decrease in HCO3- 
concentration and an increase in pH value.35 Furthermore, they stated that r-SBF 
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is unsuitable for long-term use in the biomimetic coating processes due to its 
instability.35 Thus, the present authors suggest their preference for the TRIS-
buffer over the HEPES-buffer in making the SBF solution.  
It was also reported that the rat osteoblast favorably responded to the 
coating produced by TRIS-HCl buffered SBF solutions.28 This is due to the 
resemblance of the thickness of the nanoplatelets or nanoneedles (20-30 nm) 
produced by biomimetic coatings of TRIS-HCl buffered SBF solutions with the 
bone mineral.36 Thus, 27 mM HCO3- concentrated TRIS-HCl buffered SBF 
solutions is the most effective SBF solution in the coating of artificial materials.  
7.1.3 Objectives 
The current literature revealed that biomimetic coating of collagen was 
attempted using c-SBF and r-SBF. No attempts were made to increase the coating 
rate of collagen by increasing the HCO3- ion concentration (to 27 mM) in a TRIS-
HCl buffered SBF solution (t-SBF). The performance of t-SBF was determined to 
be superior than c- and r-SBF for Ti6Al4V substrates.28 In this present study, we 
soaked porous collagen in t-SBF to evaluate the characteristics of the formed 
apatitic calcium phosphate layer.  The broad objective of the present work was to 
establish a crack-free homogeneous coating with enhanced kinetics utilizing t-
SBF. A second objective was to compare the osteoblast response to the pristine 
collagen surface with the apatite deposited collagen substrate. 
 
7.2. Experimental Procedure 
7.2.1  Collagen Preparation. Porous membranes of collagen of approximately 1 
mm thickness were obtained from Collagen Matrix Inc. (Franklin Lakes, NJ). 
These membranes were first cut into 10 x 10 mm strips and then thoroughly 
washed with deionized water. After washing, the strips were directly soaked in 
1.5x t-SBF at 37±1ºC for a period of 3 and 7 days. The following paragraph 
describes the procedure for preparing t-SBF.  
7.2.2  t-SBF Preparation. The details of preparing the 1x t-SBF solution are 
reported in Chapter 3, Section 3.2.2. 
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7.2.3  Coating Process. The coating was performed in 100 mL-capacity glass 
bottles, which contained 90 mL of SBF solution and the floating clean collagen 
membrane. Sealed bottles were kept in an oven at 37±1°C for respective 3 and 7 
day intervals. After every 48 hours, the used SBF solution was replenished. Both 
sets of recovered samples for the respective 3 and 7 day periods were thoroughly 
washed with deionized water, followed by a critical point drying process.  
7.2.4  Characterization. All samples were characterized by powder x-ray 
diffraction (XRD) (XDS 2000, Scintag, Sunnyvale, CA) using a CuKα radiation at 
40 kV and 30 mA, with a step size of 0.03° and preset time of 1 second at each 
step. Fourier-transform infrared spectroscopy (FTIR) (Nicolet 550, Thermo-
Nicolet, Woburn, MA) measurements were performed using a diamond ATR 
holder over the wave number range of 4000-525 cm-1 using 256 scan rate with a 
resolution of 4 cm-1. The surface topography of untreated collagen membrane and 
changes acquired upon soaking were analyzed using a field-emission scanning 
electron microscopy (FESEM) (S-4700, Hitachi, Tokyo, Japan) at 5kV.  
7.2.5 In Vitro Cell Culture Tests. 7F2 rat osteoblast cells (CRL-12557, 
American Type Culture Collection, Rockville, MD) were grown on 75 cm2 
culture flasks at 37ºC and 50% CO2 in α-MEM with 2 mM 1-glutamine and 1 
mM sodim pyruvate without ribonucleosides and deoxyribonucleosides, 
augmented by 10% FBS. The culture medium was changed every other day until 
the cells reached a confluence of 90-95%, as determined visually with an inverted 
microscope. The cells were then passaged using trypsin (2.5 g/L)/ EDTA (25mM) 
solution (Sigma-Aldrich Corp., St. Louis, MO, USA). The cells were further 
seeded at a concentration of 3500 cell/well on 0.14 cm3 samples for various 
assays. Cell viability and alkaline phosphatase activity measurements were 
performed after 72 hours. The cell viability assessment was performed using 
Live/Dead® Viability/Cytotoxicity Kit (L-3224, Molecular Probes, Eugene, OR). 
A working solution was prepared by mixing 5µl aliquot of Component A (4 mM 
calcein AM solution in DMSO) to 10 ml of 4 mM EthD-1 solution (20 µl of the 
Component B to 10 ml of DPBS). 100 µl of this solution was added to the cell-
containing samples along with 100 µl of cell-containing media. Samples were 
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incubated at room temperature for 30-45 minutes. After the prescribed time 
period, the fluorescence values were recorded at 494/517 nm for live cells and 
528/617 nm for dead cells by using a standard curve obtained by seeding different 
number of cells in different wells. The alkaline phosphatase (ALP) activity was 
determined using the ALP concentration and the cell extracted protein 
concentration. The ALP concentration was calculated using Enzymatic Assay of 
Phosphatase Alkaline Kit (EC 3.1.3.1, Sigma-Aldrich Corp., St. Louis, MO, 
USA). A working reagent was prepared by first mixing 2.7 ml of Reagent A (1.0 
M Diethanolamine Buffer with 0.50 mM Magnesium Chloride) with 0.30 ml of 
Reagent B (150 mM p-Nitrophenyl Phosphate Solution (pNPP) and then mixing 
the solution with 0.10 ml of cell-containing media. 100 µl of this solution was 
added to each well and thoroughly mixed and incubated at 37ºC for 30 minutes. 
Following incubation, the absorbance was recorded at 405 nm with the 
spectrophotometer at room temperature. The standard curve was obtained by 
plotting the absorbance measured at 405 nm for certain concentration against the 
concentration in µg/ml. ALP concentration of each sample was then determined 
using this standard curve and is expressend as µg-pNP/ml. The cell extracted 
protein concentration was determined in a two-step procedure. The protein was 
first extracted using M-PER™ Mammalian Protein Extraction reagent and then 
measured using BCA™ Protein Assay Kit. The cell samples were lysed by adding 
200 µl of M-PER™ Reagent to each well plate and then shaken for 5 minutes. 
Lysate was collected and transferred to microcentrifuge tubes, followed by 
centrifuging at 4000g for 10 minutes to pellet the cell debris. Supernatant was 
transferred to clean tubes for analyzing the protein concentration. To measure the 
protein amount, a working reagent (WR) was prepared by mixing 50 parts of 
BCA™ Reagent A with 1 part of BCA™ Reagent B (50:1, Reagent A:B). 200 µl 
of the above mentioned WR was added to each well and thoroughly mixed. 
Following mixing, the well plate was covered and incubated at 37ºC for 30 
minutes. The absorbance at 562 nm was measured with the spectrophotometer at 
room temperature. A standard curve was prepared by plotting the average blank-
corrected 562 nm measurement for each BSA standard versus its concentration in 
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µg/ml. Cell extracted protein concentration was then determined by using this 
standard curve and expressed as µg/ml. The ALP activity was then calculated as 
follows; ALP Activity = [(µg pNP)/139] / µg(cell extracted protein) =  µmoles 
pNPP/ µg cell protein. Osteoblast attachment/proliferation on the pellets was 
studied using SEM. Cells were first fixed by using 3.5% glutaraldehyde, and then 
dehydrated through sequential washings in 50%, 70%, 95% ethanol solutions, 
followed by 2 times in 100% ethanol. Samples were subsequently critical point-
dried, prior to sputter-coating with a thin layer of Pt.  
 
7.3.  Results 
7.3.1  XRD Analysis 
The phase identification was performed by x-ray diffraction (XRD). The 
broad peak due to collagen membrane was observed in the 2θ range of 12°-30° in 
Figure 7.1a. After soaking in 1.5x t-SBF for 7 days, peaks of apatitic calcium 
phosphates were observed at 25.9, 28.7, 32.02, and 39.75 respectively (Fig. 7.1b).  
The broadening of the apatite peaks is due to the small crystallite size of apatite. 
Figure 7.1c shows the XRD trace of a rat bone. The XRD pattern formed on 
collagen after soaking in SBF matched exactly with that of the bone.   
7.3.2 FTIR Analysis 
We used FTIR spectroscopy in order to illustrate the formation mechanism 
of bone mineral-like apatite and the chemical interaction of apatite with the 
collagen membrane. The result shows the traces for untreated collagen (Fig. 7.2a), 
collagen soaked in t-SBF for a period of 7 days (Fig. 7.2b) and a rat bone (Fig. 
7.2c).  The FTIR trace of untreated collagen (Fig. 7.2a) shows the typical bands of 
N―H stretching at 3310 cm-1 for amide A, C―H stretching at 3080 cm-1 for 
amide B, C═O stretching at 1631 cm-1 for amide I, N―H deformation at 1549 
cm-1 for amide II and N―H deformation at 1238 cm-1 for amide II bands. After 
soaking the collagen in SBF for 7 days (Fig. 7.2b), all the absorption bands of 
collagen disappeared except at 1557 and 1633 cm-1. These two are the most 
intense bands of collagen and their intensity significantly decreased after soaking  
  
 
148
       
Fig. 7.1 XRD traces of (a) untreated collagen; (b) collagen soaked in t-SBF for 7 
days; and (c) rat bone. 
 
 
 
Fig. 7.2 FTIR traces of (a) untreated collagen; (b) collagen soaked in t-SBF for 7 
days; and (c) rat bone. 
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in SBF for 7 days. This is considered an evidence of a chemical reaction between 
calcium phosphate deposited with the collagen and formation of a thick coating 
layer on collagen. Interestingly, the calcium phosphate formation did not affect 
the characteristics of collagen. The calcium phosphate coating was confirmed to 
be apatitic in nature due to the presence of PO43- bands at 1021, 608, and 561 cm-
1. The crystallinity of this apatite is low because the spectrum is not so sharp as 
that of well crystallized HA. The absorption bands present at 1420-1470 cm-1 and 
870 cm-1 also revealed the presence of CO32-. Some minor peaks are also evident 
at 961, 1122, and 1230 cm-1, which were due to the presence of HPO42- ion in the 
coating. Therefore, FTIR results confirmed that the apatitic calcium phosphate 
also contained CO32- and HPO42- ions. The absence of the stretching and the 
vibrational modes of O-H group at 3571 and 639 cm-1 confirmed that these 
coatings might not simply be named as hydroxyapatite.  
In order to further analyze the coatings, we also collected the FTIR data 
from rat bone (after cleaning and removing the bone marrow) which is depicted in 
Figure 7.2c. The similarity of the coating with the bone mineral (rat bone) is 
shown in Figure 7.2. Bone mineral is not simply “Hydroxyapatite” but is a 
defective and rather complex material doped with several mono- or divalent 
cations (Na+, K+, Mg2+, Zn2+, Fe2+, etc. upto 1.3 wt.% ) as well as with CO32- (5.8 
wt.%) and HPO42- ions with a generic formula of Ca8.3(PO4)4.3(HPO4, CO3)1.7(OH, 
CO3)0.3. The FTIR pattern of bone mineral also shows the presence of CO32- and 
HPO42-, in the coatings of this study. Henceforth, we will refer the apatitic 
calcium phosphate coating as bone mineral-like apatite. 
7.3.3 Microstructural Analysis 
The pore sizes (200 to 300 µm) and the strut morphology of the as-
received collagen foams are shown in the FE-SEM micrographs (Fig. 7.3a, low 
magnification and Fig. 7.3b, high magnification). The initial progress of the SBF-
coating, as a function of soaking time was also studied via FE-SEM (Figs. 7.4a 
and b). The low magnification (Fig. 7.4a) micrographs show that only a part of 
the collagen surface is covered with bone mineral such as apatite after soaking in 
t-SBF for 3 days. At higher magnifications, the globules of apatite become clearly  
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Fig. 7.3 FE-SEM micrographs of porous collagen prior to SBF soaking (a) low 
and (b) high magnification. 
 
 
 
   
   
Fig. 7.4 FE-SEM micrographs of collagen membrane soaked in t-SBF for a 
period of 3 days; (a) the collagen surface not fully covered in 3 days, (b) 
characteristic bone-mineral like apatite globules, (c) their attachment and 
(d) nanoporous texture of these globules becomes readily visible. 
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visible along with the underlying collagen fibrils (Fig. 7.4b). At this point, it is 
hard to predict the nature of attachment of these globules with the collagen. It can 
be either be a physically or chemically bonded attachment.   
In the case of physical attachment, the precipitates that form in the SBF 
loosely attach to the collagen surface. For chemically bonded attachments, there 
should be an interaction between bone mineral-like apatite and collagen. Figure 
7.4c shows a single globule attached to the surface of the collagen surface. In the 
same figure, initial growth of SBF produced bone mineral like apatite is evident 
on the collagen surface. Also, since the strip was floating near the top in the SBF 
containing bottle, the chances of gravity driven segregation (produced in the SBF) 
on the surface is minimized. This means that it cannot be a physical attachment 
process, but a chemically bonded process instead. (Fig. 7.4d) shows a high 
magnification micrograph of the same area. In this micrograph interlocked nano-
needle morphology is seen. A similar kind of morphology is also seen on other 
materials (Ti, Ti6Al4V, calcium phosphates) when soaked in SBF.28 At this 
magnification, we observed that the whole surface is not fully coated. Thus, we 
conclude that we needed to increase the coatings time so that the whole surface is 
coated fully and homogeneously.  
Based on our observation, we increased the time period of soaking the 
porous collagen membrane to 7 days. FE-SEM micrographs of Figure 7.5a and d 
represent our results. The low magnification micrographs show that both the 
upper struts of foams as well as those underneath are homogeneously coated (Fig. 
7.5a and b). Since the gravity effects are minimized, the foams are coated on all 
sides. This is somewhat different as opposed to coating heavier substrates such as 
metals and ceramics. As we increased the time of soaking, the strips were fully 
covered without clogging the pores with bone mineral-like apatite during the 
coating process. Higher magnification micrographs (Fig. 7.5c and d) show that 
there is no difference in morphology when the soaking time was increased from 3 
to 7 days. Low magnifications showed the globules of apatite and the high  
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Fig. 7.5 FE-SEM micrographs of collagen membrane soaked in t-SBF for a 
period of 7 days; (a) full surface coverage was observed, (b) the pores 
were not blocked, (c) the globules become clearly visible, and (d) these 
globules have the nano-porous morphology. 
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magnifications showed the nano-sized needles on these globules. Of particular 
interest was the fact that the surface of the untreated collagen membrane initially 
had micro-porosities, whereas after coating, the surface exhibited nano-porosities 
formed by the interlocking of the nano-sized needles. 
 
7.3.4  In Vitro Results 
Results of in vitro examinations with mouse osteoblast are summarized by 
the histograms in Figures 7.6a (Live/Dead cytotoxicity) and 7.6b (ALP activity). 
When compared with untreated collagen membranes, the SBF coated collagen 
resulted in an increase of attached cells and ALP activity. When viewed under 
FE-SEM, the apatitic surfaces created by t-SBF solutions were found to be the 
more viable surface for osteoblasts to attach and grow than the untreated collagen 
surfaces. Figures 7.6c and d, represent untreated collagen foams, where the 
osteoblasts were only able to attach and then extend their filopodia over the 
available surface.  Figures 7.6e and f represent osteoblast cell proliferation and 
attachment on SBF-coated foams. As evident in these figures, osteoblast cells 
were able to proliferate to the extent that even the vinculin adhesion plaques, the 
actin cytoskeleton and the stress fibers became visible. The response of the 
osteoblast to a given material is regarded as the sum of their ability to attach, 
proliferate, and differentiate. In the attachment stage, osteoblast filopodia explore 
the surface topography for areas to which a greater surface area of the cell can 
adhere. The filopodia are used in sensing the substrate, and extend over 
significant distances to find an appropriate area to attach. Osteoblast cells produce 
fewer adhesion plaques while still in the process of migration.  
 
7.4. Discussion 
To the best of our knowledge, coating of collagen by soaking in t-SBF has never 
been performed. The collagen membrane was coated fully and homogeneously 
with bone mineral-like apatite in 7 days. The coated strips were then compared 
with the untreated strips in terms of osteoblast cell response. This discussion  
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Fig. 7.6 In vitro (a) cell viability and (b) protein histograms for untreated and 
SBF-coated (7 days) collagen; Osteoblast proliferation and attachment 
on (c)-(d): untreated collagen membrane; (e)-(f): t-SBF coated collagen 
(7 days). 
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addresses the mechanisms of formation of carbonated apatitic calcium phosphates 
and the effects of several coating parameters on its formation. 
7.4.1 Formation of Bone Mineral-like Apatite in SBF Solution 
The SBF solution has a Ca/P ratio similar to that of human plasma, 2.50. 
Different chemical reagents are used to prepare different SBF solutions and 
reagents used to prepare t-SBF are mentioned in Section 3.3.2 Table 3.1. Various 
chemical reagents and their respective amounts have different effects on the 
coating phase formed in the solution. The presence of 1mM Na2HPO4 along with 
2.5 mM CaCl2.2H2O in the recipe helps in forming calcium phosphates. The 
presence of 27mM NaHCO3 plays an important role and assists in the carbonating 
the coatings. The pH of the solution is another criterion in predicting the phase 
that will precipitate. If the pH of the solution is in the range of 5 to 6, then the 
precipitating phase is dicalcium phosphate dihydrate37 and if the pH is 7.4 or 
higher, then the solution nucleates carbonated apatitic calcium phosphates. This 
means that the biomimetic coating process proceeds with the formation of 
carbonated apatitic calcium phosphates. The precipitation of carbonated apatitic 
calcium phosphates from the SBF solution may be described by the following 
reaction38, 39: 
 
(10-x-y)Ca2+ + (6-x-y)HPO42- + yHCO3- + 2H+ +2OH-       =  
                                                 Ca10-x-y[(HPO4)x(CO3)y(PO4)6-x-y](OH)2-x + (8-x)H+ 
 
The PO42- sites of the calcium phosphates formed in the SBF solution are 
substituted with HPO42- and CO32-. The carbonate ion doping into the phosphate 
tetrahedral of apatitic calcium phosphates results in the creation of charge 
compensating Ca- vacancies, which is the reason for the observed Ca-deficiencies 
of calcium phosphates synthesized in SBF solutions. The addition of 112 mM 
NaCl into SBF solution leads to the substitution of a certain fraction of Ca-sites 
with monovalent Na+ ions. Because the nature of the precipitates formed does not 
change with the addition of 5 mM K+ and/or 0.5 mM SO42- ions in the SBF 
solution, the precipitates are similar to the bone mineral. As described earlier, the 
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bone mineral consists of small sizes of biological apatite crystals containing 
substantial amounts of 4 to 6 % CO32-, 0.5% Mg2+, 0.7% Na+, and  is about 10% 
Ca-deficient.1 
7.4.2 Effect of HCO3- Ion Concentration on Coating Rate 
As previously reported, various researchers attempted to coat collagen 
substrates with bone mineral-like apatite using different SBF solutions.12-20, 32, 33 
The SBF solutions used in the past have been c-12-20 and r-SBF32, 33. In this study, 
successful coating of collagen membrane was performed by using t-SBF as shown 
by SEM micrographs in Figure 7.5. Significant differences in the coating rates 
were observed in the present research in comparison to those performed earlier. It 
has been shown by various researchers that increasing the HCO3- ion 
concentration in the SBF solution resulted in a much thicker and a homogeneous 
carbonated apatitic calcium phosphate layer on substrates.28, 34 Since t-SBF has a 
higher HCO3- concentration than c-SBF, faster coating rates are expected. By 
using t-SBF we were able to establish homogeneous coatings on collagen surface. 
It is also reported that r-SBF performed faster coating than c-SBF,28, 32 which is 
due to the higher HCO3- concentration in r-SBF. Without any modification (being 
done to either collagen or SBF), collagen was reportedly coated in 2 weeks when 
soaked in r-SBF.32 Collagen, when soaked in c-SBF, even duration of 4 weeks did 
not completely cover collagen.13 The present study reports the coating of collagen 
by t-SBF in 7 days which is faster than the coatings formed by c-SBF. Thus, for 
biomimetic coating processes the usage of t- and/or r-SBF over c-SBF is 
preferable, since they have higher concentrations of HCO3-. 
7.4.3 Effect of Buffering Agent on the Coating Morphology 
Differences were also observed in the coating morphology of the apatitic 
calcium phosphates of the present study with those reported earlier. t-SBF formed 
round globules consisting of interlocking needle-like nanosize apatitic calcium 
phosphates (Fig. 7.5c and d) which were similar to those formed by c-SBF12-20 as 
reported in previous studies.  Girija et al.32 used r-SBF for the coating of collagen 
fibrils, the precipitates formed on collagen were nearly spherical aggregates and 
clearly differed to those formed by c-SBF. These precipitates resembled those 
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formed by Bigi-SBF26 (referred to as b-SBF), which is known as a HEPES-NaOH 
buffered 27 mM HCO3- SBF solution. Similar morphological differences in the 
coatings formed by the above-mentioned 3 SBF solutions on Ti6Al4V substrates 
were reported in a recent study.28 This difference is possibly due to the different 
buffers used in the composition of the SBF solutions. While TRIS-HCl buffer was 
used in the preparation of c- and t-SBF solution, HEPES-NaOH buffer was used 
for r-SBF preparation. Therefore, the buffer used in preparing a specific SBF 
solution may have a significant influence on the morphology of the resultant 
coatings. This could be related to the effect of buffers on the stability of SBF 
solution which is explained in detail in the following paragraph. 
7.4.4 Effect of Buffering Agent on the Stability of SBF Solution 
The ionic strength of the SBF solution also plays a crucial role. c- and t-
SBF solutions have the same ionic strength values, that is, 160.5 mM whereas r-
SBF has a significantly lower value of 149.5 mM. CO2 is released from an 
aqueous solution at a faster rate if the solution has a low ionic strength.40 The 
release of CO2 from the SBF solution in turn leads to an increase in the pH 
resulting in a decrease in the level of supersaturation of the solution. It was 
observed that the pH increase in case of r-SBF solutions was higher than those 
observed in t-SBF solutions. It is known that HEPES-NaOH buffered r-SBF is 
unable to retain the HCO3- ions to the same extent as those in the TRIS-HCl 
buffered t-SBF solutions. This conclusion is corroborated by other researchers 
who emphasized that HEPES buffer was unstable and release CO2 from the 
solution.28, 34, 35 Moreover, the pH of 7.4 is the lower end of the buffering capacity 
of TRIS buffer and this facilitates the formation of calcium phosphate nuclei or 
clusters in SBF solutions.41 As compared to that, HEPES buffer has an even lower 
buffering capacity at a pH of 7.4.42-44 This explains the instability of the HEPES-
NaOH buffer and the r-SBF solutions. Moreover, the coatings deposited by t-SBF 
solutions on Ti6Al4V substrates performed much better than those formed by c-
and r-SBF, when rat osteoblasts were cultured on them.28 Thus, from the view 
point of coating stability, t-SBF was superior to r-SBF solution.  
 
  
 
158
7.4.5 In Vitro Osteoblast Response 
Untreated collagen and SBF-coated collagen membranes were compared 
via the alkaline phosphatase activity, cell density and cell proliferation tests by 
using rat osteoblasts (7F2) (Fig. 7.6). Higher cell density (Fig. 7.6a) and alkaline 
phosphatase activity (Fig. 7.6b) was observed for SBF-coated collagen 
membranes. This study compares the response of osteoblasts to two parameters: 
1) the nano-porous surface of the SBF coating and the original micro-porous 
surface of the collagen membrane and 2) the chemistry of the materials, collagen 
vs. apatitic calcium phosphates. Scientists have demonstrated that osteoblast 
response is extremely sensitive to surface roughness and porosity.45 It has also 
been previously reported that the proliferation numbers and alkaline phosphatase 
(ALP) activities of the osteoblasts improved by approximately 30-40% when 
comparing the smooth Thermanox control with the rougher calcium phosphate 
coatings.46 In addition to differences in roughness, calcium phosphates differed in 
chemical composition with Thermanox. This study also found that rat osteoblasts 
were able to easily differentiate between the chemical composition of the surfaces 
on which they were seeded. In other words, osteoblasts preferred the surface of 
bone mineral-like apatite over the surface of pristine collagen membrane. It is a 
well-known fact that the surface chemistry of a material determines the initial in 
vitro interactions of proteins, such as fibronectin with integrin cell-binding 
domains, which in turn regulate the cell adhesion process. A difference in the 
osteoblast proliferation was also seen in the SEM micrographs (Fig. 7.6c, d, e and 
f). The osteoblast spread well on the apatitic calcium phosphate coatings with 
extending their filopodia and attaching to the nano-sized needles of the bone 
mineral-like apatite (Fig. 7.6e and f). An overall improved response in terms of 
osteoblast viability, ALP activity and proliferation was encountered on the 
apatitic calcium phosphate coating (Fig. 7.6). Thus, the results show that the 
apatite-coated collagen can be successfully employed as a scaffold material that 
will prove useful in repairing bone defects. 
 
 
  
 
159
7.5. Conclusions 
Porous collagen membranes with interconnected pores were completely 
coated biomimetically with apatitic calcium phosphates in 7 days by using 1.5x t-
SBF solution. This study reports a faster and a more efficient way to coat collagen 
in comparison to the previous reported studies. SEM confirmed that the 
biomimetic process was able to cover all the surfaces without clogging the pores. 
XRD confirmed the nature of the apatitic nature of the coating and showed the 
strong similarity of the coating to the bone mineral. FTIR corroborated the results 
obtained by XRD, and showed the closeness in mimicking bone by the coatings. 
In vitro cell culture tests with 7F2 rat osteoblasts were used to compare the 
untreated collagen to the SBF-coated collagen membrane. The apatitic calcium 
phosphates formed by the SBF soaking exhibited higher cell attachment and 
alkaline phosphatase activity in comparison to the untreated collagen membrane. 
Under SEM it was determined that the osteoblasts on SBF-coated surface were 
more active and diffused more efficiently than the untreated collagen membrane.  
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